<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005176.pub4" GROUP_ID="BEHAV" ID="432403082415340300" MERGED_FROM="" MODIFIED="2010-12-08 17:35:33 +0100" MODIFIED_BY="Laura MacDonald" REVIEW_NO="E0027" REVMAN_SUB_VERSION="5.0.25" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2010-12-08 17:35:33 +0100" MODIFIED_BY="Laura MacDonald">
<TITLE>Aerobic exercise training programmes for improving physical and psychosocial health in adults with Down syndrome</TITLE>
<CONTACT MODIFIED="2010-12-08 17:35:33 +0100" MODIFIED_BY="Laura MacDonald"><PERSON ID="20062" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Régis</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>Andriolo</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>regis.andriolo@gmail.com</EMAIL_1><MOBILE_PHONE>+55 (91) 3132-4127</MOBILE_PHONE><ADDRESS><DEPARTMENT>Public Health</DEPARTMENT><ORGANISATION>Universidade do Estado do Pará</ORGANISATION><ADDRESS_1>Travessa Perebebuí, 2623</ADDRESS_1><CITY>Belém</CITY><ZIP>66087-670</ZIP><REGION>Pará</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 (91) 3276-2023</PHONE_1><FAX_1>+55 (91) 3230-1029</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-12-08 17:35:33 +0100" MODIFIED_BY="Laura MacDonald"><PERSON ID="20062" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Régis</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>Andriolo</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>regis.andriolo@gmail.com</EMAIL_1><MOBILE_PHONE>+55 (91) 3132-4127</MOBILE_PHONE><ADDRESS><DEPARTMENT>Public Health</DEPARTMENT><ORGANISATION>Universidade do Estado do Pará</ORGANISATION><ADDRESS_1>Travessa Perebebuí, 2623</ADDRESS_1><CITY>Belém</CITY><ZIP>66087-670</ZIP><REGION>Pará</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 (91) 3276-2023</PHONE_1><FAX_1>+55 (91) 3230-1029</FAX_1></ADDRESS></PERSON><PERSON ID="9DA0FCBF82E26AA2007D5B6E4992F15C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Regina</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>El Dib</LAST_NAME><POSITION>Post-Doctoral Researcher &amp; Clinical Research Associate</POSITION><EMAIL_1>re.lucci@terra.com.br</EMAIL_1><EMAIL_2>eldibr@mcmaster.ca</EMAIL_2><MOBILE_PHONE>905.297.2461</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Surgery, St. Joseph's Healthcare Hamilton</DEPARTMENT><ORGANISATION>McMaster University</ORGANISATION><ADDRESS_1>50 Charlton Avenue East</ADDRESS_1><CITY>Hamilton</CITY><ZIP>L8N 4A6</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>905.522.1155 ext. 35812</PHONE_1></ADDRESS></PERSON><PERSON ID="5A77445B82E26AA200D60225E9C102D6" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Luis</FIRST_NAME><LAST_NAME>Ramos</LAST_NAME><POSITION>Director of Department of Preventive Medicine</POSITION><EMAIL_1>LRR@uol.com.br</EMAIL_1><ADDRESS><DEPARTMENT>Discipline of Preventive Medicine</DEPARTMENT><ORGANISATION>Federal University of Sao Paulo</ORGANISATION><ADDRESS_1>Rua dos Otonis, 731</ADDRESS_1><ADDRESS_2>Vila Clementino</ADDRESS_2><CITY>Sao Paulo</CITY><ZIP>04025-002</ZIP><REGION>(Southeast)</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 557 64432</PHONE_1><FAX_1>+55 11 557 53604</FAX_1></ADDRESS></PERSON><PERSON ID="5183" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Álvaro</FIRST_NAME><MIDDLE_INITIALS>N</MIDDLE_INITIALS><LAST_NAME>Atallah</LAST_NAME><SUFFIX>MD, PhD.</SUFFIX><POSITION>Professor of Emergency Medicine and Evidence-Based Medicine, Director of Brazilian Cochrane Centre</POSITION><EMAIL_1>atallahmbe@uol.com.br</EMAIL_1><EMAIL_2>cochrane.dmed@epm.br</EMAIL_2><MOBILE_PHONE>+55 11 8173 0404</MOBILE_PHONE><ADDRESS><DEPARTMENT>Brazilian Cochrane Centre</DEPARTMENT><ORGANISATION>Universidade Federal de  São Paulo / Escola Paulista de Medicina</ORGANISATION><ADDRESS_1>Rua Pedro de Toledo 598</ADDRESS_1><ADDRESS_2>Vila Clementino</ADDRESS_2><CITY>São Paulo</CITY><ZIP>CEP 04039-001</ZIP><REGION>SP</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 5575 2970</PHONE_1><PHONE_2>+55 11 5571 4721</PHONE_2><FAX_1>+55 11 5579 0469</FAX_1></ADDRESS></PERSON><PERSON ID="BAF4536282E26AA20144426C2548692E" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Edina</FIRST_NAME><MIDDLE_INITIALS>MK</MIDDLE_INITIALS><LAST_NAME>da Silva</LAST_NAME><SUFFIX>MD, PhD</SUFFIX><POSITION>Associate Professor</POSITION><EMAIL_1>edinaksilva@terra.com.br</EMAIL_1><ADDRESS><DEPARTMENT>Emergency Medicine and Evidence Based Medicine</DEPARTMENT><ORGANISATION>Universidade Federal de São Paulo</ORGANISATION><ADDRESS_1>Rua Pedro de Toledo 598</ADDRESS_1><CITY>São Paulo</CITY><ZIP>04039-001</ZIP><REGION>São Paulo</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 55752970</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-04-21 13:42:59 +0100" MODIFIED_BY="Régis Andriolo">
<UP_TO_DATE>
<DATE DAY="19" MONTH="2" YEAR="2010"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="20" MONTH="8" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="20" MONTH="8" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="5" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2010-12-08 11:43:46 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-12-08 11:43:46 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="12" YEAR="2010"/>
<DESCRIPTION>
<P>Author contact details updated </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-12-08 10:17:59 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-12-08 10:17:59 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="4" YEAR="2010"/>
<DESCRIPTION>
<P>References updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2010-04-28 13:09:49 +0100" MODIFIED_BY="Chris Champion">
<DATE DAY="14" MONTH="4" YEAR="2010"/>
<DESCRIPTION>
<P>Review reinstated after temporary withdrawal</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-04-28 13:09:47 +0100" MODIFIED_BY="Chris Champion">
<DATE DAY="14" MONTH="4" YEAR="2010"/>
<DESCRIPTION>
<P>Full update undertaken in light of feedback received</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2010-04-28 13:09:50 +0100" MODIFIED_BY="Chris Champion">
<DATE DAY="14" MONTH="4" YEAR="2010"/>
<DESCRIPTION>
<P>Updated in response to feedback</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-04-09 11:45:35 +0100" MODIFIED_BY="Chris Champion">
<DATE DAY="13" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>Temporary withdrawal</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-18 15:19:08 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-18 15:19:11 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="3" YEAR="2007"/>
<DESCRIPTION>
<P>Searches for this version of the review were run in March 2007. No studies identified met inclusion criteria; however, relevant material has been added to the Discussion section.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="21" MONTH="3" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2010-03-31 18:47:08 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2010-03-31 18:47:08 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2010-03-31 18:47:08 +0100" MODIFIED_BY="[Empty name]">
<NAME>Capes - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION>
<P>Coordination of Improvement of Higher Education</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-12-08 16:34:35 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2010-12-08 16:33:25 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-11-11 13:47:59 +0000" MODIFIED_BY="[Empty name]">Aerobic exercise training programmes for adults with Down syndrome</TITLE>
<SUMMARY_BODY MODIFIED="2010-12-08 16:33:25 +0000" MODIFIED_BY="[Empty name]">
<P>Many people with Down syndrome have poor strength, poor muscle mass, and high body fat percentage and so are disposed to cardiovascular health problems. Although physical fitness has been suggested to improve physical and psychosocial health for a variety of healthy patient populations, information about the safety and effectiveness of aerobic exercise for adults with Down syndrome is lacking. This review identified only three small randomized trials. The results showed that only aspects of work performance (for example, maximal test time, maximal distance at the end of the exercise test) were improved after aerobic exercise training programs. Further well-designed research on larger population samples is required to evaluate potential benefits for psychosocial aspects in adults with Down syndrome.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-12-08 16:32:59 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Although physical fitness has been suggested to improve physical and psychosocial health for a variety of population profiles, there is a lack of information about the safety and effectiveness of aerobic exercise for adults with Down syndrome.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To evaluate the effectiveness and safety of aerobic exercise training programmes for physiological and psychosocial outcomes in adults with Down syndrome.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2010-12-08 16:32:15 +0000" MODIFIED_BY="[Empty name]">
<P>The following electronic databases were searched: The Cochrane Central Register of Controlled Trials (CENTRAL) (2009, Issue 1); MEDLINE (1966 to August 2009); EMBASE (1980 to August 2009); CINAHL (1982 to August 2009); LILACS (1982 to August 2009); PsycINFO (1887 to August 2009); ERIC (1966 to August 2009); Current Controlled Trials (August 2009); and Campbell Collaboration's Social, Psychological, Educational and Criminological Register (C2-SPECTR) (to August 2009). Information about ongoing clinical trials was sought by searching ClinicalTrials.gov (http://clinicaltrials.gov) (accessed August 2009), and the National Research Register (NRR) (2009 Issue 1).<I>
<BR/>
</I>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised or quasi-randomised controlled trials using supervised aerobic exercise training programmes with behavioral components accepted as co-interventions.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-04-09 11:51:00 +0100" MODIFIED_BY="Chris Champion">
<P>Two reviewers selected relevant trials, assessed methodological quality and extracted data. Where appropriate, data were pooled using meta-analysis with a random-effects model. Positive values favour the intervention group, while negative values favour the control group.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-04-21 14:51:32 +0100" MODIFIED_BY="[Empty name]">
<P>Three studies included in this systematic review used different kinds of aerobic activity: walking/jogging and rowing training for participants from 17 to 65 years old (from USA, Portugal and Israel). In the meta-analyses, only maximal treadmill grade was improved after aerobic exercise training programmes (4.26 grades (%) [95% CI 2.06, 6.45]). Other variables relative to work performance that could not be combined in a meta-analysis were also improved in the intervention group: maximal test time (<I>P</I>=0.0003), total turns of fan wheel (<I>P</I>=0.02), resistance of ergometer (p=0.003), power knee extension and flexion (p&lt;0.00001), and timed up and go test (p=0.008). Thirty other outcomes including, oxidative stress and body composition, could not be combined in the meta-analysis. Apart from work performance, trials reported no statistically significant improvements.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-12-08 16:32:59 +0000" MODIFIED_BY="[Empty name]">
<P>There is insufficient evidence to demonstrate that aerobic exercise in adults with Down syndrome improves physical or psychosocial outcomes . Although evidence exists to support improvements in physiological and psychological aspects from strategies using mixed physical activity programmes, well-conducted research examining long-term physical outcomes, adverse effects, psychosocial outcomes and costs is required before informed practice decisions can be made.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-12-08 16:34:35 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2010-04-09 13:32:07 +0100" MODIFIED_BY="Chris Champion">
<CONDITION MODIFIED="2010-04-09 13:17:13 +0100" MODIFIED_BY="Chris Champion">
<P>Down syndrome is caused by the presence of the whole or part of an extra copy of chromosome 21 (<LINK REF="REF-Hernandez-1996" TYPE="REFERENCE">Hernandez 1996</LINK>). The disorder can be diagnosed in utero by screening or karotyping, or early after birth by muscle hypotonia (poor muscle tone) and other symptoms and confirmed by karyotype analysis of a blood sample (<LINK REF="REF-Saenz-1999" TYPE="REFERENCE">Saenz 1999</LINK>). Global estimation of the incidence of Down syndrome is 1 in 1,000 to 1 in 1,200 live births (<LINK REF="REF-Irving-2008" TYPE="REFERENCE">Irving 2008</LINK>; <LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>).</P>
<P>Recent biomedical and molecular studies have suggested that the chromosomal anomaly in Down syndrome determines several alterations in protein expression patterns (<LINK REF="REF-Cabelof-2009" TYPE="REFERENCE">Cabelof 2009</LINK>) which result in particular biochemical, physiological, anatomical, and behavioural characteristics such as imbalance of the oxidative metabolism (<LINK REF="REF-Pastore-2003" TYPE="REFERENCE">Pastore 2003</LINK>; <LINK REF="REF-Roat-2007" TYPE="REFERENCE">Roat 2007</LINK>), impaired nervous system (<LINK REF="REF-Nadel-2003" TYPE="REFERENCE">Nadel 2003</LINK>), musculoskeletal disorders (<LINK REF="REF-Merrick-2002" TYPE="REFERENCE">Merrick 2002</LINK>), congenital problems of the heart (<LINK REF="REF-Vilas-Boas-2009" TYPE="REFERENCE">Vilas Boas 2009</LINK>), narrowed airways (<LINK REF="REF-Schloo-1991" TYPE="REFERENCE">Schloo 1991</LINK>; <LINK REF="REF-Uong-2001" TYPE="REFERENCE">Uong 2001</LINK>), reduced dynamic lung function (<LINK REF="REF-Khalili-2009" TYPE="REFERENCE">Khalili 2009</LINK>) obesity (<LINK REF="REF-Melville-2005" TYPE="REFERENCE">Melville 2005</LINK>), poor sinus drainage (<LINK REF="REF-Saenz-1999" TYPE="REFERENCE">Saenz 1999</LINK>), immunological abnormalities (<LINK REF="REF-Nespoli-1993" TYPE="REFERENCE">Nespoli 1993</LINK>), premature ageing (<LINK REF="REF-Cairney-2009" TYPE="REFERENCE">Cairney 2009</LINK>), poor sleep quality (<LINK REF="REF-Dyken-2003" TYPE="REFERENCE">Dyken 2003;</LINK> <LINK REF="REF-Resta-2003" TYPE="REFERENCE">Resta 2003</LINK>), and high risk of psychopathologies, dementia and behavioral problems (<LINK REF="REF-Coppus-2009" TYPE="REFERENCE">Coppus 2009;</LINK> <LINK REF="REF-Nicham-2003" TYPE="REFERENCE">Nicham 2003;</LINK> <LINK REF="REF-Urv-2008" TYPE="REFERENCE">Urv 2008</LINK>).</P>
<P>Among the characteristics specifically of interest for this systematic review, several authors have been reporting lower cardio-respiratory capacity among people with Down syndrome when compared with other populations, including people with learning disabilities who do not have Down syndrome (<LINK REF="REF-Climstein-1993" TYPE="REFERENCE">Climstein 1993</LINK>; <LINK REF="REF-Fernhall-1996" TYPE="REFERENCE">Fernhall 1996</LINK>; <LINK REF="REF-Fernhall-2001" TYPE="REFERENCE">Fernhall 2001</LINK>; <LINK REF="REF-Guerra-2003" TYPE="REFERENCE">Guerra 2003</LINK>; <LINK REF="REF-Pitetti-1992" TYPE="REFERENCE">Pitetti 1992</LINK>; <LINK REF="REF-Pitetti-1995" TYPE="REFERENCE">Pitetti 1995</LINK>), poor muscular strength and mass and high body fat percentage (<LINK REF="REF-Baptista-2005" TYPE="REFERENCE">Baptista 2005</LINK>; <LINK REF="REF-Bronks-1985" TYPE="REFERENCE">Bronks 1985</LINK>; <LINK REF="REF-Carmeli-2002" TYPE="REFERENCE">Carmeli 2002</LINK>; <LINK REF="REF-Godoy-2005" TYPE="REFERENCE">Godoy 2005</LINK>).</P>
<P>All of the above mentioned characteristics have clear repercussions on the health status and social context of people with Down syndrome and their families (<LINK REF="REF-Handerson-2007" TYPE="REFERENCE">Handerson 2007</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2010-04-09 13:17:50 +0100" MODIFIED_BY="Chris Champion">
<P>It is well established that physical activity is directly related to perceived quality of life (<LINK REF="REF-Conn-2009" TYPE="REFERENCE">Conn 2009</LINK>). Stewart et al, identified positive relationships between quality of life and aerobic capacity in older men and women in a cross-sectional study (<LINK REF="REF-Stewart-2003" TYPE="REFERENCE">Stewart 2003</LINK>). Likewise, it has been recognised that an active lifestyle is associated with longevity. Physical capacity can be a predictor of mortality as showed in a study involving more than 6000 men followed up over six years (<LINK REF="REF-Myers-2002" TYPE="REFERENCE">Myers 2002</LINK>).</P>
<P>Aerobic or sub-maximal exercises are defined as any physical activity where the predominant means of ATP (adenosine triphosphate) resynthesis is by aerobic metabolism provided by dynamic and continuous activities with large muscle groups. Common examples are swimming, running/jogging and hiking (<LINK REF="REF-Haskell-2007" TYPE="REFERENCE">Haskell 2007</LINK>). Aerobic exercise is distinct from anaerobic exercise in that the energy substrates (mainly fatty acids) are metabolised with oxygen (<LINK REF="REF-Spurway-1992" TYPE="REFERENCE">Spurway 1992</LINK>; <LINK REF="REF-Ahmaidi-1993" TYPE="REFERENCE">Ahmaidi 1993</LINK>). Aerobic exercise training programmes are considered the best way to improve cardio-respiratory capacity and achieve maximal fatty acid oxidation (<LINK REF="REF-Roberts-1996" TYPE="REFERENCE">Roberts 1996</LINK>; <LINK REF="REF-Leijssen-2002" TYPE="REFERENCE">Leijssen 2002</LINK>; <LINK REF="REF-Achten-2003" TYPE="REFERENCE">Achten 2003;</LINK> <LINK REF="REF-Haskell-2007" TYPE="REFERENCE">Haskell 2007</LINK>). To ensure aerobic activity, exercise sessions are performed at an intensity slightly below the anaerobic threshold (<LINK REF="REF-Wasserman-1973" TYPE="REFERENCE">Wasserman 1973</LINK>; <LINK REF="REF-Spurway-1992" TYPE="REFERENCE">Spurway 1992</LINK>), with working heart rates maintained at around 55 to 90% of the maximal heart rate (<LINK REF="REF-Ahmaidi-1993" TYPE="REFERENCE">Ahmaidi 1993</LINK>; <LINK REF="REF-Swain-1994" TYPE="REFERENCE">Swain 1994</LINK>). The most reliable way to ensure someone is exercising within aerobic range is to conduct ergospirometric tests because predictive methods tend to distort data (<LINK REF="REF-Franklin-1986" TYPE="REFERENCE">Franklin 1986</LINK>).</P>
<P>Besides particular physiological differences between aerobic and anaerobic exercise training programmes, prospective studies carried out with diverse populations show benefits associated with both aerobic and anaerobic exercise training programs. For example, <LINK REF="REF-Norris-1990" TYPE="REFERENCE">Norris 1990</LINK> showed advantages of aerobic over anaerobic exercise training program for well-being in police officers. In a randomized study, <LINK REF="REF-Lee-2008" TYPE="REFERENCE">Lee 2008</LINK> observed that only aerobic exercise training improved cardiorespiratory aspects, while anaerobic exercise training was associated with higher improvements of some functional aspects in patients after stroke. Among obese adults, only aerobic exercise training was associated with decreased body weight and diastolic blood pressure, but both physical exercises improved cardiorespiratory aspects (<LINK REF="REF-Schjerve-2008" TYPE="REFERENCE">Schjerve 2008</LINK>). Finaly, according to the <I>American College of Sports Medicine and the American Heart Association</I>, regular aerobic physical activities have been recommended as an effective strategy for general population to promote and maintain a good health status (<LINK REF="REF-Haskell-2007" TYPE="REFERENCE">Haskell 2007</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2010-03-22 13:35:47 +0000" MODIFIED_BY="[Empty name]">
<P>The stresses obtained through regular aerobic exercise sessions (at least three times weekly) can improve physical and psychological outcomes, including quality of life, skeletal muscle mass, body fat mass, balance and agility, and mood state (<LINK REF="REF-Blake-2009" TYPE="REFERENCE">Blake 2009</LINK>, <LINK REF="REF-DiLorenzo-1999" TYPE="REFERENCE">DiLorenzo 1999</LINK>; <LINK REF="REF-Haskell-2007" TYPE="REFERENCE">Haskell 2007</LINK>, <LINK REF="REF-Mead-2009" TYPE="REFERENCE">Mead 2009</LINK>, <LINK REF="REF-USDHHS-2002" TYPE="REFERENCE">USDHHS 2002</LINK>).<BR/>
</P>
</THEORY>
<IMPORTANCE MODIFIED="2010-04-09 13:32:07 +0100" MODIFIED_BY="Chris Champion">
<P>For adults with Down syndrome, both life expectancy and potential for active functioning in society are increasing (<LINK REF="REF-Coppus-2009b" TYPE="REFERENCE">Coppus 2009b</LINK>). However, there is a lack of consistent information about the safety and effectiveness of aerobic exercise training for this population. A systematic review of the evidence that addresses psychosocial and physiological outcomes is required.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To evaluate the effectiveness of aerobic exercise training programmes for physiological and psychosocial outcomes in adults with Down syndrome.</P>
</OBJECTIVES>
<METHODS MODIFIED="2010-12-08 16:34:31 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2010-12-08 16:34:23 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2009-09-19 22:43:46 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised or <I>quas</I>i-randomised controlled trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-12-08 16:34:03 +0000" MODIFIED_BY="[Empty name]">
<P>Adults, aged 18 or above, diagnosed with Down syndrome who are physically capable of undergoing an aerobic exercise training programme.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-03-22 13:36:08 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention group: supervised exercise training programme, defined as aerobic exercise (dynamic activities using large muscle groups, below the anaerobic threshold). Duration of exercise sessions may vary, but must have occurred at least three times each week for a minimum period of four weeks. Co-interventions could include the addition of instruction in health education or health awareness, but these may be analysed separately.<BR/>
<BR/>Control group: non-exercising group with unchanged life-styles, including activities such as physical education classes, ordinary walking, leisure activities; any non-aerobic exercise programme.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-12-08 16:34:23 +0000" MODIFIED_BY="[Empty name]">
<P>Only standardised/validated scales or instruments (for example, the SF-36 (<LINK REF="REF-Ware-1992" TYPE="REFERENCE">Ware 1992</LINK>)) were considered in this review. For future versions of this review, exceptions will be made for methods tested for their internal validity (for example, concordance inter- and intra-observer or comparison with an acceptable reference standard).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Quality of life</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Safety measures</HEADING>
<UL>
<LI>falls, exacerbation of chronic or pre-existing illness, injury or death during exercise sessions</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Professional/scholastic measures</HEADING>
<UL>
<LI>Daily tasks</LI>
<LI>Self-esteem</LI>
<LI>Family satisfaction</LI>
<LI>Sleep quality</LI>
<LI>Teacher-assessed marks</LI>
<LI>Communication skills</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Exercise Physiological data</HEADING>
<UL>
<LI>maximal heart rate;</LI>
<LI>VO<SUB>2</SUB> max/peak (maximal or peak oxygen consumption);</LI>
<LI>RER (respiratory exchange ratio);</LI>
<LI>VE (pulmonary ventilation);</LI>
<LI>AT (anaerobic threshold);</LI>
<LI>other physiological measures (analysis of blood, urine, sweat, biopsy, any other)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Measures of performance</HEADING>
<UL>
<LI>level of activity during physical test;</LI>
<LI>strength perception;</LI>
<LI>agility;</LI>
<LI>balance;</LI>
<LI>force;</LI>
<LI>other performance measures</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Biometric and body composition data</HEADING>
<UL>
<LI>Weight;</LI>
<LI>Body fat;</LI>
<LI>fat mass;</LI>
<LI>lean mass;</LI>
<LI>other biometric measures</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Cost data</HEADING>
</SUBSECTION>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2010-04-12 10:19:49 +0100" MODIFIED_BY="Chris Champion">
<ELECTRONIC_SEARCHES MODIFIED="2010-04-12 10:19:49 +0100" MODIFIED_BY="Chris Champion">
<P>The following electronic databases were searched: The Cochrane Central Register of Controlled Trials (CENTRAL) (2009, Issue 1); MEDLINE (1966 to August 2009); EMBASE (1980 to August 2009); CINAHL (1982 to August 2009); LILACS (1982 to August 2009); PsycINFO (1887 to August 2009); ERIC (1966 to August 2009); Current Controlled Trials (August 2009); and Campbell Collaboration's Social, Psychological, Educational and Criminological Register (C2- SPECTR) (to August 2009). Information about ongoing clinical trials was sought by searching ClinicalTrials.gov (http://clinicaltrials.gov) (accessed March 2007), and the National Research Register (NRR) (2009 Issue 1). No language restrictions were applied to potential trials identified for inclusion within this review. Finally, a reference manager was used to exclude duplicates (EndNote Program).<U>
<BR/>
</U>
<BR/>A general search strategy with descriptors and synonyms for "aerobic exercise" and "down syndrome" was adapted for each one of the databases (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). Additionally, specialized filters for randomized controlled trials involving human beings were used in different databases (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>, <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>). For the search strategy run in The Cochrane Library, there was no filter for randomized controlled trial (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-07-08 17:49:04 +0100" MODIFIED_BY="[Empty name]">
<P>1. Reference lists: references of the identified studies were checked for additional citations.</P>
<P>2. Personal contact: study authors and experts were contacted by email to request any unpublished data.</P>
<P>3. Supplements of the journal <I>Medicine and Science in Sports and Exercise</I> were searched.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-12-08 16:34:31 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>
<BR/>
</B>
</P>
<STUDY_SELECTION MODIFIED="2009-07-13 18:37:42 +0100" MODIFIED_BY="[Empty name]">
<P>Reviewers (RA and RED) independently screened the titles and abstracts of publications obtained by the search strategy.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2010-04-12 10:20:54 +0100" MODIFIED_BY="Chris Champion">
<P>Studies which fulfilled the inclusion criteria were obtained for data extraction by two reviewers (RA and RED) using a standard extraction form. Reviewers were not blinded to the names of the authors, institutions or journal of publication. All disagreements were resolved by consensus amongst the reviewers and planned referral to the editorial base of the Cochrane Developmental, Psychosocial and Learning Problems Group for arbitration was not necessary. Further information was requested from one trialist (<LINK REF="REF-Millar-2004" TYPE="REFERENCE">Millar 2004</LINK>).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2010-04-12 10:21:31 +0100" MODIFIED_BY="Chris Champion">
<P>Included trials were assessed by two independent reviewers (RA and EMKS) for risk of bias based on criteria described in the Cochrane Handbook (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
<P>The following domains were assessed as 'Yes' (i.e. low risk of bias), 'Unclear' (uncertain risk of bias) or 'No' (i.e. high risk of bias).</P>
<P>(1) Was the sequence generation adequate?</P>
<P>(2) Was allocation adequately concealed?</P>
<P>(3) Were incomplete outcome data adequately addressed?</P>
<P>(4) Are reports of the study free of suggestion of selective outcome reporting?</P>
<P>(5) Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-12-08 16:34:28 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Dichotomous data</HEADING>
<P>For dichotomous data, we planned to use relative risks (RR) as the effect measures with the respective 95% confidence intervals. We also planned to calculate the NNT (number need to treat, obtained from the inverse of the risk difference) for statistically significant estimate effects (p&lt;0.05).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Continuous data</HEADING>
<P>We planned to report continuous data as the difference between average results of intervention and control groups for all outcomes measured in the included studies (end-point and change from baseline) with respective 95% confidence intervals. Positive values favour the intervention group, while negative values favour the control group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Synthesis of quantitative data</HEADING>
<P>Where continuous and dichotomous data were reported in more than one study we planned to pool the results by using the random-effects meta-analysis model, since it is expected that estimate effects across different studies are not identical. This is the result of expected clinical and methodological differences between included studies. Specifically we planned to pool continuous data by using the weighted average of the differences between comparison groups where outcomes were published for more than one study and in the same scales. Where data are reported on different scales which cannot be adjusted to a uniform scale, we will analyse these data using the standardised mean difference (SMD).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Dichotomous and continuous data without sufficient information to insert in the forest plot.</HEADING>
<P>Estimate effects reported without sufficient information to insert in the forest plot, such as number of patients, number of events, mean, standard deviation and standard error as well as estimate effects for non-parametric data (for example, range, median, percentiles) were planned to be included in the "Additional Tables".</P>
</SUBSECTION>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2010-04-12 10:35:48 +0100" MODIFIED_BY="Chris Champion">
<P>Authors were contacted to supply any data missing from included studies. The percentage of participants lost to follow-up is shown in '<B>Notes'</B> in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Reviewers planned to carry out both available case analysis and intention-to-treat analysis and to compare the results. For continuous data in which it is not possible to acquire the last observation, reviewers planned to perform available data analysis. For dichotomous data, the imputation of data will be invariably used, by assuming all of them as poor outcomes, in future updates of this systematic review. The authors of this review are aware that the insertion of unavailable data does not correspond to the reality, since the strategies for imputation of data are a matter of judgement (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2010-04-12 10:36:03 +0100" MODIFIED_BY="Chris Champion">
<P>The meta-analysis used random-effects models to better account for between study variation. Consistency of results were assessed visually and by calculating I<SUP>2 </SUP>(<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>), a quantity which describes approximately the proportion of variation in point estimates that is due to heterogeneity rather than sampling error.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2010-04-12 10:55:42 +0100" MODIFIED_BY="Chris Champion">
<P>Funnel plots (trial effect versus standard error) could not be drawn as there were insufficient trials, though they may be drawn in future if sufficient data exist (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). Clinical and methodological diversity were examined as a possible cause of bias.</P>
</BIAS_ASSESSMENT>
<SUBGROUP_ANALYSIS MODIFIED="2010-12-08 16:34:31 +0000" MODIFIED_BY="[Empty name]">
<P>The authors planned to perform subgroup analyses for gender, age, type aerobic exercise and co-interventions (for example, health education elements).<BR/>
</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2010-04-12 10:56:47 +0100" MODIFIED_BY="Chris Champion">
<P>Impact of study quality on treatment effect will be analysed using sensitivity analysis. Intention-to-treat analysis versus available data analysis will also be investigated in future versions of this systematic review, because in the current review there are insufficient data to enable any sensitivity analysis.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-04-21 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2010-04-12 10:59:53 +0100" MODIFIED_BY="Chris Champion">
<SEARCH_RESULTS MODIFIED="2010-04-12 10:57:32 +0100" MODIFIED_BY="Chris Champion">
<P>The search strategy retrieved a total of 1,954 titles (without duplicates). The evolution of publications retrieved with the sensitive search strategy is shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>. Eight articles derived from three trials were found that met criteria for inclusion in the review<B> </B>(<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK>,<B> </B>
<LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>, <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>). Fifty-five articles derived from 35 studies were excluded for reasons of study designs, and/or clinical condition out of interest, and/or intervention not of interest for this review (see <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). No study was excluded by reasons of non-validated/standardized outcomes measures.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2010-04-12 10:59:53 +0100" MODIFIED_BY="Chris Champion">
<SUBSECTION>
<HEADING LEVEL="4">Comparability of included studies</HEADING>
<P>Three studies were included in this review and they were published in peer-reviewed publications. <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> (n=14) was carried out in USA. <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> (n=16) in Portugal and <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> (n=26) in Israel. <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> had similar aged participants (mean age &#8773;19 years), but <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> included participants mean aged 63 years. Only <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> and <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> included females in the sample (n=16 and 3, respectively). Duration of interventions ranged from 10 to 25 weeks with activity bouts lasting 25 to 45 minutes, with an additional 5 to 10 minutes warm-up in two studies (<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>) or active stretching exercises for five minutes (<LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>). Exercise programmes consisted of walking/jogging and rowing activities, with aerobic character guaranteed by monitoring heart rate (65 to 89% of maximal heart rate) in two studies (<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>) or walking at a speed below the threshold of breathlessness (<LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>). Participants in the three trials were involved in light physical activity, three days per week. In two studies (<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>) authors reported that participants usually used the bus as a means of transport to school, while <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> reported that all participants were resident in the foster home. With regard to cognitive status, two studies measured IQ by the Stanford Binet Intelligence Scale <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> (range from 56 to 75) and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> (mean 39.4), while <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> classified the cognitive status of participants as "trainable or educable".</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Comparison of outcome measures</HEADING>
<P>
<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> measured the following outcomes by ergoespirometric analysis: VO<SUB>2 </SUB>peak (mL·Kg·min<SUP>-1</SUP>), peak heart rate, respiratory exchange ratio (RER, VCO<SUB>2</SUB>·VO<SUB>2</SUB>
<SUP>-1</SUP>), pulmonary ventilation (VE, L·min<SUP>-1</SUP>) and maximal treadmill grade (%). The other outcome measures carried out on the rowing ergometer as well as those outcomes collected at rest were conduced exclusively by <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>. Additionally, <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> measured data on average power related to knee flexion and extension (watts/Kg), as well as functional capacity by means of timed-up and go test. See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.<BR/>
<BR/>None of the studies included in this review sought information on psychological or social outcomes for participants or their families, nor were safety measures considered as outcomes. Costs for individuals, families or service providers were not reported by authors.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-04-12 11:03:15 +0100" MODIFIED_BY="Chris Champion">
<P>Please, see Risk of Bias Tables in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">Randomisation and allocation concealment (Selection bias)</HEADING>
<P>Method of randomisation and allocation concealment were not reported in <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>. <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> did not report the method of randomisation in the paper, but described the use of random assignment, using slips pulled by another person (2:1 ratio) (<LINK REF="REF-Millar-2004" TYPE="REFERENCE">Millar 2004</LINK>), and upcoming random allocations were concealed from the investigators enrolling participants. A validated method of randomisation, coin toss, was used by <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> thus this item of internal validity was rated as of low risk of bias, but the authors did not report any method to guarantee the allocation concealment (unclear, moderate risk of bias).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding (performance bias and detection bias)</HEADING>
<P>
<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> did not blind outcome assessors to the treatment allocation (<LINK REF="REF-Millar-2004" TYPE="REFERENCE">Millar 2004</LINK>, unpublished data). It was not possible to determine whether or not <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> did blind at least outcome assessors. The characteristic of the intervention group (supervised physical exercise training) and control group (absence of supervised physical exercise training), would prevent participants and coaches from being blinded. Thus, all studies were considered as high risk of systematic error regarding performance and detection bias (blinding).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Incomplete outcomes data addressed (Attrition bias)</HEADING>
<P>
<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> reported one withdrawal after randomisation, citing the participant's abnormal electrocardiogram (<LINK REF="REF-Millar-2004" TYPE="REFERENCE">Millar 2004</LINK>, unpublished data). Therefore, from 10 patients randomized to the intervention group, nine accomplished the follow-up (10 weeks). Unfortunately, missing data could not be acquired because information concerning such matters was kept confidential on ethical grounds (<LINK REF="REF-Millar-2004" TYPE="REFERENCE">Millar 2004</LINK>, unpublished data), and authors did not carry out intent-to-treat analysis. <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> did not make available a flow-chart of participants through the study or make available any information about eventual withdrawals (thus, they were considered as of moderate risk of bias).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Selective reporting bias</HEADING>
<P>For the three included studies (<LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>, <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>), there was no suspected selection of outcomes which could reflect manipulation of data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Methodological aspects of exercise programmes</HEADING>
<P>The studies clearly described the importance of external motivation offered by the instructors during physical activities as well as familiarisation strategy with environment, procedures and evaluators, before true data collection. Moreover, <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> offered an adaptation period to the training program by dividing it in three phases based on duration of exercise bouts: phase 1, 15 minutes, three times per week for six weeks; phase 2, increasing by five more minutes per two weeks for four weeks; and phase 3, maintaining 25 minutes per session, three times a week. <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> offered treadmill training, three times/week, for 25 weeks, starting with 10 to 15 minutes as tolerated and then gradually increasing to 45 minutes, according to endurance improvements. <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> reported attendance at the exercise sessions as 85%, however such information is not a reliable source of information about adverse outcomes or the possibility of attrition bias due to unfortunate events such as falls, mechanical injury or feeling unwell during aerobic exercise training sessions. <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> reported that participants were allowed to grab the handrails for walking balance adjustments. Information concerning these aspects (safety, adaptation and attendance) were absent in <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>.<B>
<BR/>
</B>
<BR/>
<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> may have adversely affected the treatment effect by reducing exercise intensity. In this trial, monitoring of participants took place by data collectors interrupting selected participants while exercising to record their pulse. This may have changed participants' energy metabolism and affected their involvement with the activity (concentration). Moreover, this method makes it impossible to assess the intensity of the other (non-assessed) participants. <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>, on the other hand, opted to monitor the intensity of training bouts by using heart rate monitors, guaranteeing that all participants were in the aerobic range during the training. <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> asked the participants to walk at a speed below the threshold of breathlessness but as fast as they could comfortably tolerate.</P>
<P>Neither author followed-up the patients after the conclusion of the physical exercise programs aiming to look for the adherence of the participants to an active lifestyle and associated outcomes.</P>
</SUBSECTION>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-04-21 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Outcomes combined in a meta-analysis</HEADING>
<P>Two studies included in this systematic review used different kinds of aerobic interventions (walking/jogging in <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and rowing training in <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>), but the aerobic character of both activities and the similarities in descriptive data regarding age, weight, height and intellectual levels between included studies were sufficiently similar to enable meta-analyses of results of maximal treadmill tests. Both studies evaluated peak VO<SUB>2 </SUB>(mL·Kg<SUP>-1</SUP>·min<SUP>-1</SUP>), maximal heart rate (HR, beats per minute), expiratory exchange ratio (VCO<SUB>2</SUB>/VO<SUB>2</SUB>), pulmonary ventilation (VE, L·min<SUP>-1</SUP>) and maximal treadmill grade (%), all of which were measured in maximal treadmill exercise test.</P>
<P>Results of meta-analyses showed statistically significant difference favouring the intervention group only for maximal treadmill grade, a work performance variable [WMD 4.26 (95% CI 2.06, 6.45)% grade, <I>P</I>= 0.0001) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
<P>No statistically significant differences between intervention and control groups were found in the meta-analyses of VO<SUB>2 </SUB>peak, [0.30 (95% CI 3.17, 3.77) mL·Kg·min<SUP>-1</SUP>, <I>P</I>=0.87] (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>); peak heart rate [2.84 (95% CI 5.05, 10.73) beats per minute, <I>P</I>=0.48] (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>); respiratory exchange ratio (RER) [-0.01(95% CI -0.06, 0.04) VCO<SUB>2</SUB>·VO<SUB>2</SUB>
<SUP>-1</SUP>, <I>P</I>=0.70] (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>); and pulmonary ventilation [5.86 (95%CI , -4.34, 16.06) L·min<SUP>-1</SUP>, <I>P</I>=0.26] (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
<P>Despite methodological diversity regarding type of intervention (rowing vs walking), duration (10 vs 16 weeks) and methods of monitoring intensity, there was no heterogeneity that could be indicated by statistical tests (indicated by <I>P&lt;0.01</I> and I<SUP>2</SUP> &gt;50% or chi<SUP>2</SUP>&lt;df) for any of the outcomes analysed.<BR/>
<BR/>Because of the existence of one withdrawal in one of the included studies (<LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK>), intention-to-treat analysis would have been feasible had raw data been available (<LINK REF="REF-Millar-2004" TYPE="REFERENCE">Millar 2004</LINK>, unpublished data). Informal analysis showed no statistically significant differences between available case versus intention-to-treat analysis when missing data were assumed to be the same value as average baseline data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes that could not be combined in a meta-analysis</HEADING>
<P>
<LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK> reported seven variables obtained from maximal rowing ergometer test, besides those seven measured in the treadmill test. The following aspects of work performance showed statistically significant differences in favour of the intervention as compared to the control group: maximal test time (<I>P</I>=0.0003, <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>), total turns of fan wheel (<I>P</I>=0.02, <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>) and resistance of rowing ergometer (<I>P</I>=0.003). Maximal test time and maximal distance-also measured on a treadmill, but not available in the <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> study reported statistically significant results favouring the intervention group (<I>P</I>=0.005 and <I>P</I>=0.001, respectively). No statistically significant differences in variables collected in rowing ergometer test between intervention and control groups for the cardiorespiratory variables were observed (VO<SUB>2 </SUB>peak, HR, RER and VE).</P>
<P>In <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>, statistically significant differences favouring the intervention group (rowing) as compared to the control group in some variables collected at rest were observed: red blood cell oxidized glutathione (<I>P</I>=0.00001, <LINK REF="CMP-003.16" TYPE="ANALYSIS">Analysis 3.16</LINK>), a molecule thought to be an indicator of oxidative stress (a condition associated with ageing process); and plasma reduced glutathione, a molecule that is thought to be an indicator of antioxidant status (<LINK REF="REF-Uhlig-1992" TYPE="REFERENCE">Uhlig 1992</LINK>) (<I>P</I>=0.0001, <LINK REF="CMP-003.17" TYPE="ANALYSIS">Analysis 3.17</LINK>). However, the statistically significant difference observed for plasma zinc, a chemical element related with important antioxidant role (<LINK REF="REF-Berg-1996" TYPE="REFERENCE">Berg 1996</LINK>) favoured the control group (<I>P</I>=0.02, <LINK REF="CMP-003.13" TYPE="ANALYSIS">Analysis 3.13</LINK>). No statistically significant difference between comparison groups was observed for all of the other outcomes measured in this trial (<LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>): oxidative profile (red blood cell magnesium, selenium, copper, zinc, superoxide dismutase and reduced glutathione, plasma magnesium, selenium, copper, oxidized glutathione) and body composition (weight, body fat, lean mass, fat mass and bone mineral content). There was a difference favouring the control group as compared to the intervention group for thiobarbituric acid reactive substances (MD -2.28). This variable is assumed to be one of the indicators of probable oxidative stress (<LINK REF="REF-Hartman-1983" TYPE="REFERENCE">Hartman 1983</LINK>). However, the difference was not statistically significant (CI 95% -4.56, 0.00, P=0.05) (<LINK REF="CMP-003.19" TYPE="ANALYSIS">Analysis 3.19</LINK>).</P>
<P>Neither outcomes relative to oxidative stress nor body fat, lean mass, fat mass and mineral content mentioned above were measured by <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK>.</P>
<P>Only one study (<LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>) which included older participants (57 to 65 years) has reported improvements on average power for knee extension [MD 17.72 (95% CI 15.91, 19.53), p&lt;0.00001, <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>] (watts/Kg-angular velocity at 60/°s) in the intervention group as compared to the control group. The subgroup composed by men showed higher effects as compared to women, probably explaining the I<SUP>2 </SUP>(heterogeneity test) of 72%. Improvements in the intervention group as compared to the control group were also observed for average power for Knee flexion (watts/Kg-angular velocity at 60/°s) [MD 20.57 (16.56, 24.58), p=0.0001, <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>]. Again, the subgroup composed by men showed better estimate effects as compared to women. Thus, gender was assumed as the probable reason for the I<SUP>2 </SUP>(heterogeneity test) of 72%. The timed-up and go test (seconds), the other outcome measured by <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> showed results favouring the intervention group as compared to the control group [MD 3.20 (95% CI 0.83, 5.57), p=0.08, <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>]. The authors did not make available separate data for men and women for the timed-up and go test.</P>
<P>Authors of included studies did not look for outcomes closely related to the quality of life, including mood state, professional or familial satisfaction, or other psychosocial aspects, measured in a systematic way.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-12-08 16:34:35 +0000" MODIFIED_BY="[Empty name]">
<P>Only three trials were obtained, despite an extensive literature search (<LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>, <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK>, <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>). While it is possible that some unpublished trials exist, it is most likely that the inherent difficulties of carrying out trials of physical interventions for people with learning disabilities is the reason only a small number of potentially relevant studies were identified. It is also likely that assumptions about positive effects of physical activities for this population have been made based on evidence from the general population.</P>
<P>The fact that only three studies relevant to this review could be identified, and that they were very small (total number of participants equalled only 56) and gender-biased (37 males to 19 females) indicates that very little published evidence of high quality has been produced in this area. Furthermore, the large confidence interval around the point estimates for the majority of variables analysed and the diversity of data (for which meta-analysis was largely inappropriate) limit the external validity of the results obtained.<BR/>
<BR/>The only well-supported evidence of improvement in physiological outcomes besides work performance (<LINK REF="STD-Rimmer-2004" TYPE="STUDY">Rimmer 2004</LINK>), and for improvements in psychological outcomes (<LINK REF="REF-Heller-2004" TYPE="REFERENCE">Heller 2004</LINK>) comes from other controlled trials which focus on mixed physical activities, not purpose-designed aerobic exercise training programmes. <LINK REF="STD-Rimmer-2004" TYPE="STUDY">Rimmer 2004</LINK> sought to demystify outdated and inconsistent claims made by cross-sectional studies (<LINK REF="REF-Eberhard-1989" TYPE="REFERENCE">Eberhard 1989</LINK>, <LINK REF="REF-Pitetti-1992" TYPE="REFERENCE">Pitetti 1992</LINK>, <LINK REF="REF-Fernhall-1996" TYPE="REFERENCE">Fernhall 1996</LINK>) and <I>in vitro</I> studies (<LINK REF="REF-Ogawa-2002" TYPE="REFERENCE">Ogawa 2002</LINK>) which presented physiological impairments as indicators of the supposed unresponsiveness of people with Down syndrome to aerobic exercise training. Moreover, we have found an uncontrolled study in adolescents which used a case-series design and which reported favourable results on fat mass and two physiological parameters (<LINK REF="STD-Ordo_x00f1_ez-2006" TYPE="STUDY">Ordoñez 2006</LINK>).</P>
<P>Caution must be exercised when making decisions based on the results of this review. A systematic review in this area (<LINK REF="REF-Dodd-2005" TYPE="REFERENCE">Dodd 2005</LINK>) has reported superior estimate effects for VO<SUB>2 </SUB>peak, minute ventilation and work performance variables in a non-randomised study (<LINK REF="STD-Tsimaras-2004" TYPE="STUDY">Tsimaras 2004</LINK>, cited in our systematic review as a secondary reference: Tsimaras 2003) as compared to the other randomised studies included by them (<LINK REF="STD-Rimmer-2004" TYPE="STUDY">Rimmer 2004</LINK>, <LINK REF="STD-Tsimaras-2004" TYPE="STUDY">Tsimaras 2004</LINK>, <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>). It is fundamental to remember that non-randomised studies tend to overestimate the effects of treatments (<LINK REF="REF-Kunz-2006" TYPE="REFERENCE">Kunz 2006</LINK>). Moreover <LINK REF="REF-Dodd-2005" TYPE="REFERENCE">Dodd 2005</LINK> employed inclusion criteria which were wide, taking in all types of exercise training programmes (for example, aerobic, resistive, jumping and plyometric exercises), allowing therefore the inclusion of <LINK REF="STD-Rimmer-2004" TYPE="STUDY">Rimmer 2004</LINK> in its meta-analysis (<LINK REF="REF-Dodd-2005" TYPE="REFERENCE">Dodd 2005</LINK>).</P>
<P>Because studies do not currently formally measure occurrence of falls, injuries or adverse events at all during exercise sessions, it is not yet possible to recommend a physical exercise training program as an invariably safe intervention for adults with Down syndrome. However, <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>, a study which included older Down syndrome participants (mean age 63 years old), reported no undesired event during a six-month exercise training program.</P>
<P>There is a rich literature on the optimum duration of exercise for adults without learning disabilities (<LINK REF="REF-Carr-2003" TYPE="REFERENCE">Carr 2003</LINK>, <LINK REF="REF-Haskell-2007" TYPE="REFERENCE">Haskell 2007</LINK>, <LINK REF="REF-Moreira-1999" TYPE="REFERENCE">Moreira 1999</LINK>, <LINK REF="REF-Seggar-1998" TYPE="REFERENCE">Seggar 1998</LINK>); however, less is published concerning exercise for those with learning disabilities and the duration of exercise training used by the authors here (10 weeks in <LINK REF="STD-Millar-1993" TYPE="STUDY">Millar 1993</LINK> and 16 weeks in <LINK REF="STD-Varela-2001" TYPE="STUDY">Varela 2001</LINK>) could provoke discussion about benefits. Possible differences caused by dose-response effects of an aerobic exercise training programme for Down syndrome remain uncertain.</P>
<P>Besides the paucity of evidence regarding outcomes concerned with psychosocial health as well as safety and cost aspects of an aerobic exercise as an option for health of adults with Down syndrome, the reviewers also have detected a lack of information about long-term potential benefits. We would advise future trialists to emphasise strategies which follow up how well participants continue to adhere to an active lifestyle and measure its consequences, including maintenance of body composition, psychosocial health and independence.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-04-12 11:30:23 +0100" MODIFIED_BY="Chris Champion">
<IMPLICATIONS_PRACTICE MODIFIED="2010-03-22 14:03:53 +0000" MODIFIED_BY="[Empty name]">
<P>In spite of the fact that moderate and regular physical exercise is popular and established as a sound lifestyle decision both for health and as an intervention to improve quality of life in the general population, current evidence from published studies suggest that in adults with Down syndrome work performance outcomes may be improved by aerobic exercise training programmes, regardless of age range within adulthood. However, cardiorespiratory measures may not be improved. Aspects of quality of life like psychosocial outcomes, safety, and dose-response await systematic evaluation. Overall, the effectiveness of aerobic exercise training programmes in improving the health of adults with Down syndrome remains uncertain.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-04-12 11:30:23 +0100" MODIFIED_BY="Chris Champion">
<P>In light of increasing popular demand for physical fitness, the importance of well-conducted trials involving physical training for people with learning disabilities should be recognised, particularly for those people with conditions like Down syndrome which put special stresses on their physiology. There is a paucity of published studies investigating the effects of aerobic exercise for adults with Down syndrome and an even smaller number of trials of sufficient methodological rigour to determine the effectiveness of such intervention.</P>
<P>Future trials should ensure that interventions are appropriate to this population, with regard to physiological and behavioural aspects. Methodological procedures should guarantee precision for a range of intensities and motivation levels. Standardised methods and outcome assessment is required to facilitate future data syntheses, particularly where sample sizes are small. Formal quantifying of adverse events such as mechanical injuries, falls or feeling unwell during exercise sessions is essential. Cost-benefit analyses of aerobic interventions should be conducted. Finally, attention to long-term maintenance of any improvements caused by aerobic exercise training programmes, adherence of participants to an active lifestyle, and issues of dose-response are all important to the design of future research.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-04-13 11:02:15 +0100" MODIFIED_BY="[Empty name]">
<P>We would like to thank the authors Carmeli, Coleman, Fernhall, Millar, Monteiro, Rimmer, Tomporowski and Tsimaras who made both articles and information available promptly; Ms Eileen Brunt and Ms Joanne Abbott from the University of Bristol for their assistance with search terms appropriate to various electronic databases; Ms Jane Dennis (CDPLPG review group coordinator), Bernardo Garcia de Oliveira Soares and Álvaro Nagib Atallah (Brazilian Cochrane Centre) for precious methodological support, and finally, Turíbio Leite de Barros Neto, Alcione Moscardi and Raul Santo who believed in scientific questions that inspired this work. We also would like to thank Mark Elkins and the staff of PEDro database of randomised trials in physiotherapy for their feedback on this systematic review.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Luiz Roberto Ramos (LRR) was responsible for conception of this review. Design and overall coordination of this protocol was done by Regis Andriolo (RA). RA was responsible for the search strategy, in collaboration with trial search coordinators Eileen Brunt and Jo Abbott of the Cochrane Developmental, Psychosocial and Learning Problems Group. RA ran searches and, in collaboration with Regina El Dib, screened search results, obtained papers, screened retrieved papers against inclusion criteria, appraised quality of papers and extracted data. RA wrote to authors of papers for additional information and to locate potentially relevant unpublished or ongoing studies.</P>
<P>RA was responsible for data management for the review, although data was entered independently by the two reviewers. RA analysed and interpreted data and wrote up the results, whilst seeking clinical, methodological, policy and consumer perspectives. </P>
<P>ANA and EMKS updated the review and inserted considerations on "Discussion".</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2010-03-22 14:07:54 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>
<I>Assessment of risk of bias of included studies</I>
</B>
</P>
<P>The items to evaluate the risk of systematic error were modified according to suggested by the updated Cochrane Handbook (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
<P>
<B>
<I>Types of outcomes</I>
</B>
</P>
<P>Besides validated methods to evaluate the outcomes, the authors of this review will also accept studies with methods tested for their internal validity (eg., concordance inter- and intra-observer or comparison with an acceptable reference standard).</P>
<P>Outcomes were properly divided to "primary outcomes" and "secondary outcomes".</P>
<P>
<B>
<I>Sensitivity analysis</I>
</B>
</P>
<P>Impact of study quality on treatment effect will be analysed using sensitivity analysis. Intention-to-treat analysis versus available data analysis will also be investigated in future versions of this systematic review, because until now there was insufficient data to enable any sensitivity analysis.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2010-04-14 11:47:24 +0100" MODIFIED_BY="Chris Champion">
<P>This review was temporarily withdrawn following the authors' attention being brought to a misclassification of an excluded study. This updated version now includes that study, and has been fully updated with new searches.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-12-08 11:33:52 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2010-12-08 11:31:14 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2010-04-12 11:50:40 +0100" MODIFIED_BY="Chris Champion">
<STUDY DATA_SOURCE="PUB" ID="STD-Carmelli-2002" MODIFIED="2009-09-23 01:23:45 +0100" MODIFIED_BY="[Empty name]" NAME="Carmelli 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-09-23 01:23:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Carmeli E, Kessel S, Coleman R, Ayalon M</AU>
<TI>Effects of a treadmill walking program on muscle strength and balance in elderly people with Down syndrome</TI>
<SO>Journals of Gerontology Series A: Biological Sciences &amp; Medical Sciences</SO>
<YR>2002</YR>
<VL>57</VL>
<NO>2</NO>
<PG>M106-10</PG>
<IDENTIFIERS MODIFIED="2009-09-18 11:22:55 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 11:22:55 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11818429 "/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Millar-1993" MODIFIED="2010-04-12 11:47:06 +0100" MODIFIED_BY="Chris Champion" NAME="Millar 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Millar AL, Fernhall B, Burkett LN, Tymeson G</AU>
<TI>Effects of training on maximal oxygen uptake of mentally retarded adolescents and adults</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1988</YR>
<VL>20</VL>
<PG>S28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Millar AL, Fernhall B, Burkett LN</AU>
<TI>Effects of aerobic training for individuals with down syndrome</TI>
<SO>Palaestra</SO>
<YR>1995</YR>
<VL>11</VL>
<NO>4</NO>
<PG>10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 11:47:06 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Millar AL, Fernhall B, Burkett LN</AU>
<TI>Effects of aerobic training in adolescents with Down syndrome</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1993</YR>
<VL>25</VL>
<NO>2</NO>
<PG>270-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8450732"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Varela-2001" MODIFIED="2010-04-12 11:50:40 +0100" MODIFIED_BY="Chris Champion" NAME="Varela 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baptista F, Varela A, Teixeira P, Sardinha LB</AU>
<TI>The effects of aerobic exercise training program in body composition on Down syndrome subjects (Abstract no. 183)</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1996</YR>
<VL>28</VL>
<NO>5 [Supplement: Annual Meeting Abstracts]</NO>
<PG>31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 11:49:18 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Monteiro CP, Varela A, Pinto M, Neves J, Felisberto GM, Vaz C et al</AU>
<TI>Effect of an aerobic training on magnesium, trace elements and antioxidant systems in a Down syndrome population</TI>
<SO>Magnesium Research</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>1</NO>
<PG>65-71</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9339840"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Varela A, Sardinha LB, Pitetti KH</AU>
<TI>Effects of aerobic rowing training in adults with Down syndrome</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1997</YR>
<VL>29</VL>
<NO>Suppl</NO>
<PG>S244 [Abstract]</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 11:50:40 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Varela A, Sardinha LB, Pitetti KH</AU>
<TI>Effects of an aerobic rowing training regimen in young adults with Down syndrome</TI>
<SO>American Journal of Mental Retardation</SO>
<YR>2001</YR>
<VL>106</VL>
<NO>2</NO>
<PG>135</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11321604"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2010-12-08 11:31:14 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Agiovlasitis-2009" MODIFIED="2010-04-12 11:51:01 +0100" MODIFIED_BY="Chris Champion" NAME="Agiovlasitis 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-04-12 11:51:01 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agiovlasitis S, McCubbin JA, Pavol MJ, Widrick JJ</AU>
<TI>Economy and preferred speed of walking in adults with and without down syndrome</TI>
<SO>Adapted Physical Activity Quarterly</SO>
<YR>2009</YR>
<VL>26</VL>
<NO>2</NO>
<PG>118-30</PG>
<IDENTIFIERS MODIFIED="2009-09-17 00:29:52 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:29:52 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2010242967"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-09-17 00:27:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:27:39 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2010242967"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aguiar-2008" MODIFIED="2010-04-12 11:51:17 +0100" MODIFIED_BY="Chris Champion" NAME="Aguiar 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-04-12 11:51:17 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aguiar AS Jr., Tuon T, Albuquerque MM, Rocha GS, Speck AE, Araujo JC, et al</AU>
<TI>The exercise redox paradigm in the Down's syndrome: improvements in motor function and increases in blood oxidative status in young adults</TI>
<SO>Journal of Neural Transmission</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>12</NO>
<PG>1643-50</PG>
<IDENTIFIERS MODIFIED="2009-09-17 02:30:51 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 02:30:51 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18795225"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Angulo_x002d_Barroso-2008" MODIFIED="2010-04-12 11:51:59 +0100" MODIFIED_BY="Chris Champion" NAME="Angulo-Barroso 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-09-18 11:43:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Angulo-Barroso R, Burghardt AR, Lloyd M, Ulrich DA</AU>
<TI>Physical activity in infants with Down syndrome receiving a treadmill intervention</TI>
<SO>Infant Behavior &amp; Development</SO>
<YR>2008</YR>
<VL>31</VL>
<NO>2</NO>
<PG>255-69</PG>
<IDENTIFIERS MODIFIED="2009-09-18 11:36:52 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 11:36:52 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2008-03374-010"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-09-18 11:41:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Angulo-Barroso RM, Wu J, Ulrich DA</AU>
<TI>Long-term effect of different treadmill interventions on gait development in new walkers with Down syndrome</TI>
<SO>Gait Posture</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>2</NO>
<PG>231-8</PG>
<IDENTIFIERS MODIFIED="2009-09-18 11:41:04 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 11:41:04 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17940103"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 11:51:59 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ulrich DA, Lloyd MC, Tiernan CW, Looper JE, Angulo-Barroso RM</AU>
<TI>Effects of intensity of treadmill training on developmental outcomes and stepping in infants with Down syndrome: a randomized trial</TI>
<SO>Physical Therapy</SO>
<YR>2008</YR>
<VL>88</VL>
<NO>1</NO>
<PG>114-22</PG>
<IDENTIFIERS MODIFIED="2009-09-18 11:44:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 11:44:39 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17940103"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-09-18 11:49:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu J, Looper J, Ulrich BD, Ulrich DA, Angulo-Barroso RM</AU>
<TI>Exploring effects of different treadmill interventions on walking onset and gait patterns in infants with Down syndrome</TI>
<SO>Developmental Medicine &amp; Child Neurology</SO>
<YR>2007</YR>
<VL>49</VL>
<NO>11</NO>
<PG>839-45</PG>
<IDENTIFIERS MODIFIED="2009-09-18 11:49:14 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 11:49:14 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2007-18585-010"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-09-18 11:51:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu J, Ulrich DA, Looper J, Tiernan CW, Angulo-Barroso RM</AU>
<TI>Strategy adoption and locomotor adjustment in obstacle clearance of newly walking toddlers with Down syndrome after different treadmill interventions</TI>
<SO>Experimental Brain Research</SO>
<YR>2008</YR>
<VL>186</VL>
<NO>2</NO>
<PG>261-72</PG>
<IDENTIFIERS MODIFIED="2009-09-18 11:51:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 11:51:46 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2008-06239-007"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Black-2007" MODIFIED="2009-09-17 00:52:36 +0100" MODIFIED_BY="[Empty name]" NAME="Black 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-09-17 00:52:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Black DP, Smith BA, Wu J, Ulrich BD</AU>
<TI>Uncontrolled manifold analysis of segmental angle variability during walking: Preadolescents with and without Down syndrome</TI>
<SO>Experimental Brain Research</SO>
<YR>2007</YR>
<VL>183</VL>
<NO>4</NO>
<PG>511-21</PG>
<IDENTIFIERS MODIFIED="2009-09-17 00:52:36 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:52:36 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2008-01182-009"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Black-2009" MODIFIED="2009-09-17 00:36:25 +0100" MODIFIED_BY="[Empty name]" NAME="Black 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-09-17 00:36:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Black D, Chang CL, Kubo M, Holt K, Ulrich B</AU>
<TI>Developmental trajectory of dynamic resource utilization during walking: toddlers with and without Down syndrome</TI>
<SO>Human Movement Science</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>1</NO>
<PG>141-54</PG>
<IDENTIFIERS MODIFIED="2009-09-17 00:36:25 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:36:25 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18977548"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-09-17 00:32:17 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:32:17 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="18977548"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bricout-2008" MODIFIED="2009-09-17 00:55:18 +0100" MODIFIED_BY="[Empty name]" NAME="Bricout 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-09-17 00:55:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bricout VA, Guinot M, Faure P, Flore P, Eberhard Y, Garnier P, et al</AU>
<TI>Are hormonal responses to exercise in young men with Down's syndrome related to reduced endurance performance?</TI>
<SO>Journal of Neuroendocrinology</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>5</NO>
<PG>558-65</PG>
<IDENTIFIERS MODIFIED="2009-09-17 00:55:18 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:55:18 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2008-04912-003"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carmeli-2004" MODIFIED="2010-04-12 11:52:38 +0100" MODIFIED_BY="Chris Champion" NAME="Carmeli 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-04-12 11:52:38 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carmeli E, Barchad S, Masharawi Y, Coleman R</AU>
<TI>Impact of a walking program in people with Down syndrome</TI>
<SO>Journal of Strength &amp; Conditioning Research</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>1</NO>
<PG>180-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="14971963"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chang-2009" MODIFIED="2010-12-08 11:31:14 +0000" MODIFIED_BY="[Empty name]" NAME="Chang 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-08 11:31:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chang CL, Kubo M, Ulrich BD</AU>
<TI>Emergence of neuromuscular patterns during walking in toddlers with typical development and with Down syndrome</TI>
<SO>Human Movement Science</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>2</NO>
<PG>283-96</PG>
<IDENTIFIERS MODIFIED="2009-09-17 01:38:43 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 01:38:43 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19272665"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dupont-1987" MODIFIED="2010-04-21 14:02:23 +0100" MODIFIED_BY="[Empty name]" NAME="Dupont 1987" YEAR="1987">
<REFERENCE MODIFIED="2010-04-21 14:02:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Dupont BB, Schulmann D</AU>
<TI>Dance therapy with physical therapy for children with Down syndrome</TI>
<SO>Education Resources Information Center</SO>
<YR>1987</YR>
<PG>19</PG>
<IDENTIFIERS MODIFIED="2009-09-17 03:04:21 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 03:04:21 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ED300960"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dyer-1994" NAME="Dyer 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dyer SM</AU>
<TI>Physiological effects of a 13-week physical fitness program on Down syndrome subjects</TI>
<SO>Pediatric Exercise Science</SO>
<YR>1994</YR>
<VL>6</VL>
<PG>88-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Dyer S. The effects of a health related fitness program on the physical, cognitive, social and affective development of Down syndrome subjects aged eight to seventeen. James Cook University of North Queensland 1992.&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="BOOK">
<AU>Dyer SM</AU>
<SO>The effects of a health related fitness program on the physical, cognitive, social and affective development of Down syndrome subjects aged eight to seventeen (PhD thesis)</SO>
<YR>1992</YR>
<PB>James Cook University of North Queensland</PB>
<CY>Cairns/Townsville, Australia</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eberhard-1989" MODIFIED="2009-09-17 00:23:14 +0100" MODIFIED_BY="[Empty name]" NAME="Eberhard 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-09-17 00:23:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eberhard Y, Eterradossi J, Rapacchi B</AU>
<TI>Physical aptitudes to exertion in children with Down's syndrome</TI>
<SO>Journal of Mental Deficiency Research</SO>
<YR>1989</YR>
<VL>33</VL>
<NO>Pt 2</NO>
<PG>167-74</PG>
<IDENTIFIERS MODIFIED="2009-09-17 00:23:14 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:23:14 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2524596"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eberhard-1990" NAME="Eberhard 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="BOOK_SECTION">
<AU>Eberhard Y, Eterradossi J</AU>
<TI>Effects of physical exercise in adolescents with Down's syndrome</TI>
<SO>Adapted Physical Activity - an interdisciplinary approach</SO>
<YR>1990</YR>
<VL>16</VL>
<PG>281-287</PG>
<ED>Springer-Verlag, Berlin Heidelberg</ED>
<PB>Doll-Tepper/Dahms/Döll/von Selzam C.</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eberhard-1993" MODIFIED="2010-04-12 11:55:12 +0100" MODIFIED_BY="Chris Champion" NAME="Eberhard 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-04-12 11:55:12 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eberhard Y, Eterradossi J, Foulon T, Groslambert P</AU>
<TI>Changes in plasma lipoproteins in adolescents with trisomy 21 in response to a physical endurance test</TI>
<TO>Variations des lipoprotéines plasmatiques chez des adolescents trisomiques 21 en réponse à un test déndurance physique</TO>
<SO>Pathologie Biologie (Paris)</SO>
<YR>1993</YR>
<VL>41</VL>
<NO>5</NO>
<PG>482-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8414682"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eberhard-1997" MODIFIED="2010-04-12 11:55:20 +0100" MODIFIED_BY="Chris Champion" NAME="Eberhard 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-04-12 11:55:20 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Eberhard Y, Eterradossi J, Debû B</AU>
<TI>Biological changes induced by physical activity in individuals with Down syndrome</TI>
<SO>Adapted Physical Activity Quaterly</SO>
<YR>1997</YR>
<VL>14</VL>
<NO>2</NO>
<PG>166-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flore-2008" MODIFIED="2010-04-12 11:55:35 +0100" MODIFIED_BY="Chris Champion" NAME="Flore 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-04-12 11:55:35 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flore P, Bricout VA, van Biesen D, Guinot M, Laporte F, Pepin JL et al</AU>
<TI>Oxidative stress and metabolism at rest and during exercise in persons with Down syndrome</TI>
<SO>European Journal of Cardiovascular Prevention and Rehabilitation</SO>
<YR>2008</YR>
<VL>15</VL>
<NO>1</NO>
<PG>35-42</PG>
<IDENTIFIERS MODIFIED="2009-09-17 01:43:35 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 01:43:35 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18277183"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galli-2008" MODIFIED="2009-09-17 01:46:37 +0100" MODIFIED_BY="[Empty name]" NAME="Galli 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-09-17 01:46:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Galli M, Rigoldi C, Brunner R, Virji-Babul N, Giorgio A</AU>
<TI>Joint stiffness and gait pattern evaluation in children with Down syndrome</TI>
<SO>Gait Posture</SO>
<YR>2008</YR>
<VL>28</VL>
<NO>3</NO>
<PG>502-6</PG>
<IDENTIFIERS MODIFIED="2009-09-17 01:46:37 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 01:46:37 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18455922"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guerra-2009" MODIFIED="2009-09-17 00:16:49 +0100" MODIFIED_BY="[Empty name]" NAME="Guerra 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-09-17 00:16:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guerra M, Gine-Garriga M, Fernhall B</AU>
<TI>Reliability of Wingate testing in adolescents with Down syndrome</TI>
<SO>Pediatric Exercise Science</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>1</NO>
<PG>47-54</PG>
<IDENTIFIERS MODIFIED="2009-09-17 00:16:49 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 00:16:49 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19411710"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heffernan-2009" MODIFIED="2009-09-17 01:49:36 +0100" MODIFIED_BY="[Empty name]" NAME="Heffernan 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-09-17 01:49:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heffernan KS, Sosnoff JJ, Ofori E, Jae SY, Baynard T, Collier SR, et al</AU>
<TI>Complexity of force output during static exercise in individuals with Down syndrome</TI>
<SO>Journal of Applied Physiology</SO>
<YR>2009</YR>
<VL>106</VL>
<NO>4</NO>
<PG>1227-33</PG>
<IDENTIFIERS MODIFIED="2009-09-17 01:49:36 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 01:49:36 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19164775"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lafferty-2005" NAME="Lafferty 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lafferty ME</AU>
<TI>A stair-walking intervention strategy for children with Down's syndrome</TI>
<SO>Journal of Bodywork and Movement Therapies</SO>
<YR>2005</YR>
<VL>9</VL>
<NO>1</NO>
<PG>65-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LaForme-2007" MODIFIED="2009-09-18 01:48:06 +0100" MODIFIED_BY="[Empty name]" NAME="LaForme 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-09-18 01:47:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>LaForme Fiss AC, B</AU>
<TI>Effect of increased practice time using sensorimotor groups on gross motor skill acquisition for children with Down syndrome</TI>
<SO>ProQuest Information &amp; Learning: US [Thesis]</SO>
<YR>2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LaForme-2009" MODIFIED="2009-09-18 02:12:20 +0100" MODIFIED_BY="[Empty name]" NAME="LaForme 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-09-18 02:12:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>LaForme Fiss AC, Effgen SK, Page J, Shasby S</AU>
<TI>Effect of sensorimotor groups on gross motor acquisition for young children with Down syndrome</TI>
<SO>Pediatric Physical Therapy</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>2</NO>
<PG>158-66</PG>
<IDENTIFIERS MODIFIED="2009-09-18 02:12:20 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 02:12:20 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19440"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lewis-2005" NAME="Lewis 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lewis CL, Fragala-Pinkham MA</AU>
<TI>Effects of aerobic conditioning and strength training on a child with Down syndrome: a case study</TI>
<SO>Pediatric Physical Therapy</SO>
<YR>2005</YR>
<VL>17</VL>
<NO>1</NO>
<PG>30-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lloyd-2008" MODIFIED="2009-09-17 02:04:22 +0100" MODIFIED_BY="[Empty name]" NAME="Lloyd 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-09-17 02:04:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Lloyd MC</AU>
<TI>Physical activity of preschool age children with and without Down syndrome (Thesis)</TI>
<SO>University of Michigan</SO>
<YR>2008</YR>
<IDENTIFIERS MODIFIED="2009-09-17 02:04:22 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 02:04:22 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2010060819"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mendon_x00e7_a-2009" MODIFIED="2010-04-12 11:57:30 +0100" MODIFIED_BY="Chris Champion" NAME="Mendonça 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-04-12 11:57:30 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mendonça GV, Pereira FD, Fernhall B</AU>
<TI>Walking economy in male adults with Down syndrome</TI>
<SO>European Journal of Applied Physiology</SO>
<YR>2009</YR>
<VL>105</VL>
<NO>1</NO>
<PG>153-7</PG>
<IDENTIFIERS MODIFIED="2009-09-17 02:08:56 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 02:08:56 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18850109"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mendon_x00e7_a-2009a" MODIFIED="2010-04-12 11:57:41 +0100" MODIFIED_BY="Chris Champion" NAME="Mendonça 2009a" YEAR="2009">
<REFERENCE MODIFIED="2010-04-12 11:57:41 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mendonça GV, Pereira FD</AU>
<TI>Influence of long-term exercise training on submaximal and peak aerobic capacity and locomotor economy in adult males with Down's syndrome</TI>
<SO>Medical Science Monitor</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>2</NO>
<PG>CR33-9</PG>
<IDENTIFIERS MODIFIED="2009-09-17 02:50:37 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 02:50:37 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19179964"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ordo_x00f1_ez-2006" MODIFIED="2010-04-21 14:06:55 +0100" MODIFIED_BY="[Empty name]" NAME="Ordoñez 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-04-12 12:09:20 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ordoñez FJ, Rosety M, Rosety-Rodriguez M</AU>
<TI>Influence of 12-week exercise training on fat mass percentage in adolescents with Down syndrome</TI>
<SO>Medical Science Monitor</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>10</NO>
<PG>CR416-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:09:29 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ordoñez FJ, Rosety M, Rosety-Rodriguez M</AU>
<TI>Regular exercise did not modify significantly superoxide dismutase activity in adolescents with Down's syndrome</TI>
<SO>British Journal of Sports Medicine</SO>
<YR>2006</YR>
<VL>40</VL>
<NO>8</NO>
<PG>717-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:08:23 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ordoñez FJ, Rosety M, Rosety-Rodriguez M</AU>
<TI>Regular physical activity increases glutathione peroxidase activity in adolescents with Down syndrome Regular physical activity increases glutathione peroxidase activity in adolescents with Down syndrome</TI>
<SO>Clinical Journal of Sport Medicine</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>4</NO>
<PG>355-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:10:02 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ordoñez FJ, Rosety-Rodriguez M, Rosety M</AU>
<TI>A 12-week physical activity program increases glucose-6-phosphate-dehydrogenase activity in Down syndrome adolescents [Portuguese]</TI>
<SO>Medicina (Buenos Aires)</SO>
<YR>2005</YR>
<VL>65</VL>
<NO>6</NO>
<PG>518-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:10:20 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ordoñez FJ, Rosety-Rodriguez M</AU>
<TI>Correlation between glutathione peroxidase activity and anthropometrical parameters in adolescents with Down syndrome</TI>
<SO>Research in Developmental Disabilities</SO>
<YR>2006</YR>
<VL>28</VL>
<NO>1</NO>
<PG>105-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="16563697"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:09:04 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ordoñez FJ, Rosety-Rodriguez M</AU>
<TI>Regular exercise attenuated lipid peroxidation in adolescents with Down's syndrome</TI>
<SO>Clinical Biochemistry</SO>
<YR>2007</YR>
<VL>40</VL>
<NO>1-2</NO>
<PG>141-2</PG>
<IDENTIFIERS MODIFIED="2009-09-17 02:43:51 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 02:43:51 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17123499"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-21 14:06:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosety-Rodriguez M, Rosety I, Fornieles-Gonzalez G, Diaz A, Rosety M, Ordoñez FJ</AU>
<TI>A 12-week aerobic training program reduced plasmatic allantoin in adolescents with Down syndrome</TI>
<SO>British Journal of Sports Medicine</SO>
<YR>2008</YR>
<VL>[Epub ahead of print]</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:13:22 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosety-Rodriguez M, Rosety M, Ordoñez FJ</AU>
<TI>Influence of regular exercise on erythrocyte catalase activity in adolescents with Down syndrome</TI>
<SO>Medicina Clínica (Barcelona)</SO>
<YR>2006</YR>
<VL>127</VL>
<NO>14</NO>
<PG>533-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Per_x00e1_n-1997" MODIFIED="2010-04-12 12:16:46 +0100" MODIFIED_BY="Chris Champion" NAME="Perán 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-04-12 12:16:26 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perán S, Gil JL, Ruiz F, Balbuena FR</AU>
<TI>Athletic competition and Down syndrome</TI>
<SO>Down Syndrome: Research and Practice</SO>
<YR>1996</YR>
<VL>4</VL>
<NO>1</NO>
<PG>43-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:16:18 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Perán S, Gil JL, Ruiz F, Fernandez-Pastor V</AU>
<TI>Development of physical response after athletics training in adolescents with Down's syndrome</TI>
<SO>Scandinavian Journal of Medicine &amp; Science in Sports</SO>
<YR>1997</YR>
<VL>7</VL>
<NO>5</NO>
<PG>283-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9338946"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perán S, Gil JL, Ruiz F, Sánchez JJ</AU>
<TI>Improvements in physical performance and its clinical repercussions dispose people with Down syndrome to the entertainment in athletism</TI>
<TO>Evolución Del rendimiento físico y su repercusión sobre los aspectos clínicos tras el entrenamiento de atletismo en personas con síndrome de Down</TO>
<SO>Síndrome de Down. Artículos y Resumes Científicos</SO>
<YR>1995</YR>
<VL>25</VL>
<PG>1-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:16:32 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perán S, Gil JL, Ruiz F</AU>
<TI>Athleticism and sporting activities in people with Down syndrome</TI>
<TO>Atletismo y deporte en personas con síndrome de Down: Research de un proyecto</TO>
<SO>Revista Síndrome de Down</SO>
<YR>1996</YR>
<VL>13</VL>
<NO>1</NO>
<PG>27-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:16:46 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perán S, Gil JL</AU>
<TI>The contribution of the practice of athletics in the promotion of health, recuperation and rehabilitation in people with Down syndrome</TI>
<TO>Contribución a la práctica del atletismo a la promoción de la salud, recuperación y rehabilitación de personas con síndrome de Down</TO>
<SO>Revista Síndrome de Down</SO>
<YR>1995</YR>
<VL>12</VL>
<NO>1</NO>
<PG>103-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rimmer-2004" MODIFIED="2010-04-12 12:17:15 +0100" MODIFIED_BY="Chris Champion" NAME="Rimmer 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-04-12 12:17:06 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heller T, Hsieh K, Rimmer JH</AU>
<TI>Attitudinal and psychosocial outcomes of a fitness and health education program on adults with Down syndrome</TI>
<SO>American Journal of Mental Retardation</SO>
<YR>2004</YR>
<VL>109</VL>
<NO>2</NO>
<PG>175-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:17:15 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rimmer JH, Heller T, Wang E, Valerio I</AU>
<TI>Improvements in physical fitness in adults with Down syndrome</TI>
<SO>American Journal of Mental Retardation</SO>
<YR>2004</YR>
<VL>109</VL>
<NO>2</NO>
<PG>165-74</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15000673"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valerio I, Rimmer J H, Heller T, Wang E</AU>
<TI>Improving physical fitness in adults with Down syndrome</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>2003</YR>
<VL>35 (Suppl)</VL>
<NO>5</NO>
<PG>S374</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shields-2008" MODIFIED="2009-09-18 11:29:43 +0100" MODIFIED_BY="[Empty name]" NAME="Shields 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-09-18 11:29:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shields N, Taylor NF, Dodd KJ</AU>
<TI>Effects of a community-based progressive resistance training program on muscle performance and physical function in adults with Down syndrome: a randomized controlled trial</TI>
<SO>Archives of Physical Medicine &amp; Rehabilitation</SO>
<YR>2008</YR>
<VL>89</VL>
<NO>7</NO>
<PG>1215-20</PG>
<IDENTIFIERS MODIFIED="2009-09-18 11:29:43 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-18 11:29:43 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18586124"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Skrobak-1980" MODIFIED="2010-04-12 12:17:36 +0100" MODIFIED_BY="Chris Champion" NAME="Skrobak 1980" YEAR="1980">
<REFERENCE MODIFIED="2010-04-12 12:17:36 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="BOOK_SECTION">
<AU>Skrobak-Kaczynski J, Vavik T</AU>
<TI>Physical fitness and trainability of young male patients with Down syndrome</TI>
<SO>Children and Exercise: IX. International Series on Sports Sciences</SO>
<YR>1980</YR>
<VL>10</VL>
<PG>300-16</PG>
<ED>K. Berg&amp; B. O. Ericksson</ED>
<PB>Park Press</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2007" MODIFIED="2010-04-12 12:17:47 +0100" MODIFIED_BY="Chris Champion" NAME="Smith 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-04-12 12:17:47 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith BA, Kubo M, Black DP, Holt KG, Ulrich BD</AU>
<TI>Effect of practice on a novel task - walking on a treadmill: preadolescents with and without Down syndrome</TI>
<SO>Physical Therapy</SO>
<YR>2007</YR>
<VL>87</VL>
<NO>6</NO>
<PG>766-77</PG>
<IDENTIFIERS MODIFIED="2009-09-17 02:13:28 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-17 02:13:28 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17442836"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsimaras-2004" MODIFIED="2010-04-12 12:18:06 +0100" MODIFIED_BY="Chris Champion" NAME="Tsimaras 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-04-12 12:17:59 +0100" MODIFIED_BY="Chris Champion" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsimaras V, Giagazoglou P, Fotiadou E, Christoulas K, Angelopoulou N</AU>
<TI>Jog-walk training cardiorespiratory fitness of adults with Down syndrome</TI>
<SO>Perceptual &amp; Motor Skills</SO>
<YR>2003</YR>
<VL>96</VL>
<NO>3 [Pt 2]</NO>
<PG>1239-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-04-12 12:18:06 +0100" MODIFIED_BY="Chris Champion" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tsimaras VK, Fotiadou EG</AU>
<TI>Effect of training on the muscle strength and dynamic balance ability of adults with down syndrome</TI>
<SO>Journal of Strength &amp; Conditioning Research</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>2</NO>
<PG>343-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15142004"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ulrich-2001" MODIFIED="2009-09-19 22:29:23 +0100" MODIFIED_BY="[Empty name]" NAME="Ulrich 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-09-19 22:29:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rizzo T</AU>
<TI>Early intervention to facilitate walking in infants with Down syndrome (book)</TI>
<SO>Adapted Physical Activity Quarterly</SO>
<YR>2002</YR>
<VL>19</VL>
<NO>3</NO>
<PG>397</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE=" 3000012613"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ulrich DA, Ulrich BD, Angulo-Kinzler RM, Yun J</AU>
<TI>Treadmill training of Infants with Down syndrome: evidence-based developmental outcomes</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>108</VL>
<NO>5</NO>
<PG>E84</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11694668"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weber-1986" MODIFIED="2009-09-18 03:05:55 +0100" MODIFIED_BY="[Empty name]" NAME="Weber 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-09-18 03:05:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Weber RC, A P</AU>
<TI>Effects of strength development training programs for Down's Syndrome adolescents [Thesis]</TI>
<SO>ProQuest Information &amp; Learning: US</SO>
<YR>1986</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-12-08 11:33:52 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2010-12-08 11:33:52 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Achten-2003" MODIFIED="2010-04-12 12:18:36 +0100" MODIFIED_BY="Chris Champion" NAME="Achten 2003" TYPE="JOURNAL_ARTICLE">
<AU>Achten J, Jeukendrup AE</AU>
<TI>Maximal fat oxidation during exercise in trained men</TI>
<SO>International Journal of Sports Medicine</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>8</NO>
<PG>603-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="14598198"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ahmaidi-1993" NAME="Ahmaidi 1993" TYPE="JOURNAL_ARTICLE">
<AU>Ahmaidi S, Hardy JM, Varray A, Collomp K, Mercier J, Prefault C</AU>
<TI>Respiratory gas exchange indices used to detect the blood lactate accumulation threshold during an incremental exercise test in young athletes</TI>
<SO>European Journal of Applied Physiology &amp; Occupational Physiology</SO>
<YR>1993</YR>
<VL>66</VL>
<NO>1</NO>
<PG>31-36</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8425510"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baptista-2005" MODIFIED="2010-04-12 12:19:04 +0100" MODIFIED_BY="Chris Champion" NAME="Baptista 2005" TYPE="JOURNAL_ARTICLE">
<AU>Baptista F, Varela A, Sarbinha LB</AU>
<TI>Bone mineral mass in males and females with and without Down syndrome</TI>
<SO>Osteoporosis International</SO>
<YR>2005</YR>
<VL>16</VL>
<PG>380-8</PG>
<IDENTIFIERS MODIFIED="2009-11-06 23:15:03 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-06 23:15:03 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00198-004-1687-1"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Berg-1996" MODIFIED="2010-04-12 12:19:25 +0100" MODIFIED_BY="Chris Champion" NAME="Berg 1996" TYPE="JOURNAL_ARTICLE">
<AU>Berg JM, Shi Y</AU>
<TI>The galvanization of biology: a growing appreciation for the roles of zinc</TI>
<SO>Science</SO>
<YR>1996</YR>
<VL>271</VL>
<NO>5252</NO>
<PG>1081-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8599083"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blake-2009" MODIFIED="2010-04-12 12:19:40 +0100" MODIFIED_BY="Chris Champion" NAME="Blake 2009" TYPE="JOURNAL_ARTICLE">
<AU>Blake H, Mo P, Malik S, Thomas S</AU>
<TI>How effective are physical activity interventions for alleviating depressive symptoms in older people? A systematic review</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>10</NO>
<PG>873-87</PG>
<IDENTIFIERS MODIFIED="2009-11-04 23:50:02 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 23:50:02 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19675114"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bronks-1985" MODIFIED="2010-04-12 12:19:59 +0100" MODIFIED_BY="Chris Champion" NAME="Bronks 1985" TYPE="JOURNAL_ARTICLE">
<AU>Bronks R, Parker AW</AU>
<TI>Anthropometric observation of adults with Down syndrome</TI>
<SO>American Journal of Mental Deficiency</SO>
<YR>1985</YR>
<VL>90</VL>
<NO>1</NO>
<PG>110-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3161328"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cabelof-2009" MODIFIED="2010-04-12 12:20:19 +0100" MODIFIED_BY="Chris Champion" NAME="Cabelof 2009" TYPE="JOURNAL_ARTICLE">
<AU>Cabelof DC, Patel HV, Chen Q, van Remmen H, Matherly LH, Ge Y et al</AU>
<TI>Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome</TI>
<SO>Blood</SO>
<YR>2009</YR>
<VL>114</VL>
<NO>13</NO>
<PG>2752-63</PG>
<IDENTIFIERS MODIFIED="2009-11-04 20:49:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 20:49:07 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19633202"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cairney-2009" MODIFIED="2010-04-12 12:20:36 +0100" MODIFIED_BY="Chris Champion" NAME="Cairney 2009" TYPE="JOURNAL_ARTICLE">
<AU>Cairney CJ, Sanguinetti G, Ranghini E, Chantry AD, Nostro MC, Bhattacharyya A et al</AU>
<TI>A systems biology approach to Down syndrome: identification of Notch/Wnt dysregulation in a model of stem cells aging</TI>
<SO>Biochimica et Biophysica Acta</SO>
<YR>2009</YR>
<VL>1792</VL>
<NO>4</NO>
<PG>353-63</PG>
<IDENTIFIERS MODIFIED="2009-11-04 21:25:26 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 21:25:26 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19419698"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Carmeli-2002" MODIFIED="2010-04-12 12:20:51 +0100" MODIFIED_BY="Chris Champion" NAME="Carmeli 2002" TYPE="JOURNAL_ARTICLE">
<AU>Carmeli E, Aylon M, Barchad S, Sheklow SL, Reznick AZ</AU>
<TI>Isokinetic leg strength of institutionalized older adults with mental retardation with and without Down's syndrome</TI>
<SO>Journal of Strength &amp; Conditioning Research</SO>
<YR>2002</YR>
<VL>16</VL>
<NO>2</NO>
<PG>316-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11991788"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Carr-2003" MODIFIED="2010-12-08 11:33:52 +0000" MODIFIED_BY="[Empty name]" NAME="Carr 2003" TYPE="JOURNAL_ARTICLE">
<AU>Carr M, Jones J</AU>
<TI>Physiological effects of exercise on stroke survivors</TI>
<SO>Topics in Stroke Rehabilitation</SO>
<YR>2003</YR>
<VL>9</VL>
<NO>4</NO>
<PG>57-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Climstein-1993" MODIFIED="2010-04-12 12:21:20 +0100" MODIFIED_BY="Chris Champion" NAME="Climstein 1993" TYPE="JOURNAL_ARTICLE">
<AU>Climstein M, Pitetti KH, Barret PJ, Campbell KD</AU>
<TI>The accuracy of predicting treadmill VO2max for adults with mental retardation, with and without Down's syndrome, using ACSM gender- and activity-specific regression equations</TI>
<SO>Journal of Intellectual Disability Research</SO>
<YR>1993</YR>
<VL>37</VL>
<NO>Pt 6</NO>
<PG>521-31</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8123998"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Conn-2009" MODIFIED="2010-04-12 12:21:35 +0100" MODIFIED_BY="Chris Champion" NAME="Conn 2009" TYPE="JOURNAL_ARTICLE">
<AU>Conn VS, Hafdahl AR, Brown LM</AU>
<TI>Meta-analysis of quality-of-life outcomes from physical activity interventions</TI>
<SO>Nursing Research</SO>
<YR>2009</YR>
<VL>58</VL>
<NO>3</NO>
<PG>175-83</PG>
<IDENTIFIERS MODIFIED="2009-11-04 23:07:27 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 23:07:27 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19448521"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Coppus-2009" MODIFIED="2010-12-08 11:28:47 +0000" MODIFIED_BY="[Empty name]" NAME="Coppus 2009" TYPE="JOURNAL_ARTICLE">
<AU>Coppus A, Evenhuis H, Verberne GJ, Visser F, van Gool P, Eikelenboom P et al</AU>
<TI>Dementia and mortality in persons with Down's syndrome</TI>
<SO>Journal of Intellectual Disability Research</SO>
<YR>2006</YR>
<VL>50</VL>
<NO>Pt 10</NO>
<PG>768-77</PG>
<IDENTIFIERS MODIFIED="2009-11-04 22:03:37 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 22:03:37 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16961706"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Coppus-2009b" MODIFIED="2010-04-12 12:22:27 +0100" MODIFIED_BY="Chris Champion" NAME="Coppus 2009b" TYPE="JOURNAL_ARTICLE">
<AU>Coppus AM, Evenhuis HM, Verberne GJ, Visser FE, Oostra BA, Eikelenboom P et al</AU>
<TI>Survival in elderly persons with Down syndrome</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2008</YR>
<VL>56</VL>
<NO>12</NO>
<PG>2311-6</PG>
<IDENTIFIERS MODIFIED="2009-11-07 00:56:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-07 00:56:00 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19093931"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-DiLorenzo-1999" NAME="DiLorenzo 1999" TYPE="JOURNAL_ARTICLE">
<AU>DiLorenzo TM, Bargman EP, Stucky-Ropp R, Brassington GS, Frensch PA, La Fountaine T</AU>
<TI>Long-term effects of aerobic exercise on psychological outcomes</TI>
<SO>Preventive Medicine</SO>
<YR>1999</YR>
<VL>28</VL>
<NO>1</NO>
<PG>75-85</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9973590"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dodd-2005" MODIFIED="2010-04-12 12:23:06 +0100" MODIFIED_BY="Chris Champion" NAME="Dodd 2005" TYPE="JOURNAL_ARTICLE">
<AU>Dodd KJ Shields N</AU>
<TI>A systematic review of the outcomes of cardiovascular exercise programs for people with Down syndrome</TI>
<SO>Archives of Physical Medicine &amp; Rehabilitation</SO>
<YR>2005</YR>
<VL>86</VL>
<NO>10</NO>
<PG>2051-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dyken-2003" MODIFIED="2010-04-12 12:23:31 +0100" MODIFIED_BY="Chris Champion" NAME="Dyken 2003" TYPE="JOURNAL_ARTICLE">
<AU>Dyken ME, Lin-Dyken DC, Poulton S, Zimmerman MB, Sedars E</AU>
<TI>Prospective polysomnographic analysis of obstructive sleep apnea in down syndrome</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>2003</YR>
<VL>157</VL>
<NO>7</NO>
<PG>655-60</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12860786"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Eberhard-1989" MODIFIED="2010-04-12 12:23:41 +0100" MODIFIED_BY="Chris Champion" NAME="Eberhard 1989" TYPE="JOURNAL_ARTICLE">
<AU>Eberhard Y, Eterradossi J, Rapacchi B</AU>
<TI>Physical aptitudes to exertion in children with Down's syndrome</TI>
<SO>Journal of Mental Deficiency Research</SO>
<YR>1989</YR>
<VL>33</VL>
<NO>Pt2</NO>
<PG>167-74</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2524596"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2010-04-12 12:23:56 +0100" MODIFIED_BY="Chris Champion" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey-Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphic test</TI>
<SO>British Medical Journal</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fernhall-1996" MODIFIED="2010-04-12 12:24:31 +0100" MODIFIED_BY="Chris Champion" NAME="Fernhall 1996" TYPE="JOURNAL_ARTICLE">
<AU>Fernhall BO, Pitetti KH, Rimmer JH, McCubbin JA, Rintala P, Millar AL et al</AU>
<TI>Cardiorespiratory capacity of individuals with mental retardation including Down syndrome</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>1996</YR>
<VL>28</VL>
<NO>3</NO>
<PG>366-71</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8776225"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fernhall-2001" MODIFIED="2010-04-12 12:24:46 +0100" MODIFIED_BY="Chris Champion" NAME="Fernhall 2001" TYPE="JOURNAL_ARTICLE">
<AU>Fernhall BO, McCubbin JA, Pitetti KH, Rintala P, Rimmer JH, Millar L et al</AU>
<TI>Prediction of maximal heart rate in individuals with mental retardation</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2001</YR>
<VL>33</VL>
<NO>10</NO>
<PG>1655-60</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11581548"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Franklin-1986" MODIFIED="2010-04-12 12:25:14 +0100" MODIFIED_BY="Chris Champion" NAME="Franklin 1986" TYPE="JOURNAL_ARTICLE">
<AU>Franklin BA</AU>
<TI>Pitfalls in estimating aerobic capacity from exercise time or workload</TI>
<SO>Applied Cardiology</SO>
<YR>1986</YR>
<VL>14</VL>
<PG>25-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Godoy-2005" MODIFIED="2010-04-12 12:25:56 +0100" MODIFIED_BY="Chris Champion" NAME="Godoy 2005" TYPE="JOURNAL_ARTICLE">
<AU>Godoy JR, Barros J de F</AU>
<TI>Palmar force in Down syndrome people. Analysis of involved muscles</TI>
<TO>Força de preensão palmar em portadores da síndrome de Down e análise dos músculos envolvidos neste movimento</TO>
<SO>Acta Cirúrgica Brasileira</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>Suppl 1</NO>
<PG>159-66</PG>
<IDENTIFIERS MODIFIED="2009-11-06 20:11:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-06 20:11:39 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17768804"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guerra-2003" MODIFIED="2010-04-12 12:26:14 +0100" MODIFIED_BY="Chris Champion" NAME="Guerra 2003" TYPE="JOURNAL_ARTICLE">
<AU>Guerra M, Liorenz N, Fernhall B</AU>
<TI>Chronotropic incompetence in persons with Down syndrome</TI>
<SO>Archives of Physical Medicine &amp; Rehabilitation</SO>
<YR>2003</YR>
<VL>84</VL>
<NO>11</NO>
<PG>1604-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="14639558"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Handerson-2007" MODIFIED="2010-04-12 12:26:39 +0100" MODIFIED_BY="Chris Champion" NAME="Handerson 2007" TYPE="JOURNAL_ARTICLE">
<AU>Henderson A, Lynch SA, Wilkinson S, Hunter M</AU>
<TI>Adults with Down's syndrome: the prevalence of complications and health care in the community</TI>
<SO>British Journal of General Practice</SO>
<YR>2007</YR>
<VL>57</VL>
<NO>534</NO>
<PG>50-5</PG>
<IDENTIFIERS MODIFIED="2009-11-04 22:27:31 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 22:27:31 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17244425"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hartman-1983" MODIFIED="2010-04-12 12:26:46 +0100" MODIFIED_BY="Chris Champion" NAME="Hartman 1983" TYPE="JOURNAL_ARTICLE">
<AU>Hartman PE</AU>
<TI>Putative mutagens and carcinogens in foods. IV. Malonaldehyde (malondialdehyde)</TI>
<SO>Environ Mutagen</SO>
<YR>1983</YR>
<VL>5</VL>
<NO>4</NO>
<PG>603-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6347681"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Haskell-2007" MODIFIED="2010-04-12 12:27:10 +0100" MODIFIED_BY="Chris Champion" NAME="Haskell 2007" TYPE="JOURNAL_ARTICLE">
<AU>Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA et al</AU>
<TI>Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association</TI>
<SO>Circulation</SO>
<YR>2007</YR>
<VL>116</VL>
<NO>9</NO>
<PG>1081-93</PG>
<IDENTIFIERS MODIFIED="2009-11-05 16:14:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-05 16:14:15 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17671237"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Heller-2004" MODIFIED="2010-04-12 12:27:22 +0100" MODIFIED_BY="Chris Champion" NAME="Heller 2004" TYPE="JOURNAL_ARTICLE">
<AU>Heller T, Hsieh K, Rimmer JH</AU>
<TI>Attitudinal and psychosocial outcomes of a fitness and health education program on adults with Down syndrome</TI>
<SO>American Journal of Mental Retardation</SO>
<YR>2004</YR>
<VL>109</VL>
<NO>2</NO>
<PG>175-85</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15000672"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hernandez-1996" MODIFIED="2010-04-12 12:27:31 +0100" MODIFIED_BY="Chris Champion" NAME="Hernandez 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hernandez D, Fisher EMC</AU>
<TI>Down syndrome genetics: unravelling a multifactorial disorder</TI>
<SO>Human Molecular Genetics</SO>
<YR>1996</YR>
<VL>5</VL>
<PG>1411-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2010-04-12 12:27:42 +0100" MODIFIED_BY="Chris Champion" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-07-13 17:36:11 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]</TI>
<SO>The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org</SO>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Irving-2008" MODIFIED="2010-04-12 12:28:12 +0100" MODIFIED_BY="Chris Champion" NAME="Irving 2008" TYPE="JOURNAL_ARTICLE">
<AU>Irving C, Basu A, RichmondS, Burn J, Wren C</AU>
<TI>Twenty-year trends in prevalence and survival of Down syndrome</TI>
<SO>European Journal of Human Genetics</SO>
<YR>2008</YR>
<VL>16</VL>
<NO>11</NO>
<PG>1336-40</PG>
<IDENTIFIERS MODIFIED="2009-11-04 22:43:43 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 22:43:43 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18596694"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Khalili-2009" MODIFIED="2010-03-22 13:28:47 +0000" MODIFIED_BY="[Empty name]" NAME="Khalili 2009" TYPE="JOURNAL_ARTICLE">
<AU>Khalili MA, Elkins MR</AU>
<TI>Aerobic exercise improves lung function in children with intellectual disability: a randomised trial</TI>
<SO>The Australian Journal of Physiotherapy</SO>
<YR>2009</YR>
<VL>55</VL>
<NO>3</NO>
<PG>171-5</PG>
<IDENTIFIERS MODIFIED="2010-03-22 13:28:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-03-22 13:28:47 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19681738"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kunz-2006" MODIFIED="2008-07-08 19:41:35 +0100" MODIFIED_BY="[Empty name]" NAME="Kunz 2006" TYPE="COCHRANE_REVIEW">
<AU>Kunz R, Vist G, Oxman AD</AU>
<TI>Randomisation to protect against selection bias in healthcare trials</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-07-08 19:41:35 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-07-08 19:41:35 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.MR000012.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lee-2008" MODIFIED="2010-04-12 12:29:12 +0100" MODIFIED_BY="Chris Champion" NAME="Lee 2008" TYPE="JOURNAL_ARTICLE">
<AU>Lee MJ, Kilbreath SL, Singh MF, Zeman B, Lord SR, Raymond J, Davis GM</AU>
<TI>Comparison of effect of aerobic cycle training and progressive resistance training on walking ability after stroke: a randomized sham exercise-controlled study</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2008</YR>
<VL>56</VL>
<NO>6</NO>
<PG>976-85</PG>
<IDENTIFIERS MODIFIED="2009-11-08 21:38:02 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-08 21:38:02 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18422947"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leijssen-2002" MODIFIED="2010-04-12 12:29:25 +0100" MODIFIED_BY="Chris Champion" NAME="Leijssen 2002" TYPE="JOURNAL_ARTICLE">
<AU>Leijssen DP, Saris WH, Wagenmakers AJ, Senden JM, Van Baak MA</AU>
<TI>Effects of exercise training at different intensities on fat metabolism of obese</TI>
<SO>Obesity Research</SO>
<YR>2002</YR>
<VL>92</VL>
<NO>3</NO>
<PG>1300-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mead-2009" MODIFIED="2009-11-05 00:40:18 +0000" MODIFIED_BY="[Empty name]" NAME="Mead 2009" TYPE="COCHRANE_REVIEW">
<AU>Mead GE, Morley W, CampbellP, Greig CA, McMurdo M, Lawlor DA</AU>
<TI>Exercise for depression</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2009-11-05 00:40:18 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-05 00:40:18 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Melville-2005" MODIFIED="2010-04-12 12:29:45 +0100" MODIFIED_BY="Chris Champion" NAME="Melville 2005" TYPE="JOURNAL_ARTICLE">
<AU>Melville CA, Cooper SA, McGrother CW, Thorp CF, Collacott R</AU>
<TI>Obesity in adults with Down syndrome: a case-control study.</TI>
<SO>Journal of Intellectual Disability Research</SO>
<YR>2005</YR>
<VL>49</VL>
<NO>Pt 2</NO>
<PG>125-33</PG>
<IDENTIFIERS MODIFIED="2009-11-04 21:07:17 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 21:07:17 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15634321 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Merrick-2002" MODIFIED="2010-04-12 12:29:59 +0100" MODIFIED_BY="Chris Champion" NAME="Merrick 2002" TYPE="JOURNAL_ARTICLE">
<AU>Merrick J, Ezra E, Josef B, Hendel D, Steinberg DM, Wientroub S</AU>
<TI>Musculoskeletal problems in Down syndrome European paediatric orthopaedic society survey: the Israeli sample</TI>
<SO>Journal of Pediatric Orthopaedics, Part B</SO>
<YR>2002</YR>
<VL>9</VL>
<NO>3</NO>
<PG>185-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Millar-2004" NAME="Millar 2004" NOTES="&lt;p&gt;Inquery and respective responses by the author&lt;br&gt;1. Was there adaptation strategy for exercise program?&lt;br&gt;For the training program itself, we used THR, and started with walking. We progressed to a combination of walking and jogging, and by the end were jogging the majority of the time.&lt;/p&gt;&lt;p&gt;2. Was there follow-up?&lt;br&gt;No&lt;/p&gt;&lt;p&gt;3. What kind of exercise was it used (treadmill, field or gymnasium)?&lt;br&gt;As noted above , we used walking and jogging, which we did outside. We actually used the block around the school as our track.&lt;/p&gt;&lt;p&gt;4. Were there other outcomes measured, besides ones reported in the paper?&lt;br&gt;I also looked at body composition , which did not change. However, I was unable to control for their caloric intake, and found that some parents had increased the individuals intake, as they thought they would need &amp;quot;extra energy&amp;quot;.&lt;/p&gt;&lt;p&gt;5. Initial and final values and respective standard deviations of maximal test times for control group were only partially informed in the paper. Is it possible to send us this information?&lt;br&gt;Because this was published so long ago, I do not have all of the original information easily accessible. I do have the treadmill grades with standard deviations, which would reflect the times. The exercise group went from 20.3% (SD=4) to 23.1% (SD = 4.1), while the control group went from 19.4% (SD = 3.1) to 18.1% (SD=2.4).&lt;/p&gt;&lt;p&gt;6. Baseline and final values of maximal treadmill grade (%) and respective standard deviations of both groups, experimental and control were informed only by graphic, but we would like to see the real values.&lt;br&gt;See above&lt;/p&gt;&lt;p&gt;7. How was allocation made (details)?&lt;br&gt;Random - not sure what type of details you want&amp;#8230;&lt;br&gt;Second contact: ...&amp;quot;block assignment - using slips pulled by another person (first two slips with names to exercise, next one to control)&amp;quot;.&lt;/p&gt;&lt;p&gt;8. Was there blinded assessment of outcomes?&lt;br&gt;No. This was not deemed necessary for physiological measures.&lt;/p&gt;&lt;p&gt;9. Details of attrition (gender and time of withdrawal). Did you collect data from the person who drop-out?&lt;br&gt;There was no attrition.&lt;br&gt;Second contact in september 20, 2004: &amp;quot;Only 9 of the 10 were able to participate in the traiing program. One individual was not allowed to participate due to an abnormal ECG durung the initial treadmill test. After the training started, none of the 9 dropped out&amp;quot;.&lt;/p&gt;&lt;p&gt;10. Is it possible to send us mean and standard deviation of individual changes or individual data for all outcomes measured (raw data)?&lt;br&gt;Mean and standard deviations are group statistics. I cannot send individual data as it is considered confidential.&lt;br&gt;&lt;/p&gt;" TYPE="CORRESPONDENCE">
<AU>Millar AL</AU>
<SO>Personal correspondence (email to Regis Andriolo concerning method of randomisation and missing data)</SO>
<YR>2004 (20 September)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moreira-1999" MODIFIED="2010-04-12 12:30:17 +0100" MODIFIED_BY="Chris Champion" NAME="Moreira 1999" TYPE="JOURNAL_ARTICLE">
<AU>Moreira WD, Fuchs FD, Ribeiro JP, Appel LJ</AU>
<TI>The effects of two aerobic training intensities on ambulatory blood pressure in hypertensive patients: results of a randomized trial</TI>
<SO>Journal of clinical epidemiology</SO>
<YR>1999</YR>
<VL>52</VL>
<NO>7</NO>
<PG>637-42</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10391657"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Myers-2002" NAME="Myers 2002" TYPE="JOURNAL_ARTICLE">
<AU>Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE</AU>
<TI>Exercise capacity and mortality among among men referred for exercising testing</TI>
<SO>New England Journal of Medicine</SO>
<YR>2002</YR>
<VL>346</VL>
<NO>11</NO>
<PG>793-801</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11893790"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nadel-2003" MODIFIED="2010-04-12 12:30:37 +0100" MODIFIED_BY="Chris Champion" NAME="Nadel 2003" TYPE="JOURNAL_ARTICLE">
<AU>Nadel L</AU>
<TI>Down's syndrome: a genetic disorder in biobehavioral perspective</TI>
<SO>Genes Brain &amp; Behavior</SO>
<YR>2003</YR>
<VL>2</VL>
<NO>3</NO>
<PG>156-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nespoli-1993" MODIFIED="2010-04-12 12:30:46 +0100" MODIFIED_BY="Chris Champion" NAME="Nespoli 1993" TYPE="JOURNAL_ARTICLE">
<AU>Nespoli L, Burgio GR, Ugazio AG, Maccario R</AU>
<TI>Immunological features of Down&#8217;s syndrome: a review</TI>
<SO>Journal of Intellectual Disability Research</SO>
<YR>1993</YR>
<VL>37</VL>
<NO>Pt 6</NO>
<PG>543&#8211;51</PG>
<IDENTIFIERS MODIFIED="2010-03-22 13:34:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-03-22 13:34:13 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8124000"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nicham-2003" MODIFIED="2010-04-12 12:31:20 +0100" MODIFIED_BY="Chris Champion" NAME="Nicham 2003" TYPE="JOURNAL_ARTICLE">
<AU>Nicham R, Weitzdorfer R, Hauser E, Freidl M, Schubert M, Wurst E et al</AU>
<TI>Spectrum of cognitive, behavioural and emotional problems in children and young adults with Down syndrome</TI>
<SO>Journal of Neural Transmission. Supplementum</SO>
<YR>2003</YR>
<VL>67</VL>
<PG>173-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Norris-1990" MODIFIED="2010-04-12 12:31:27 +0100" MODIFIED_BY="Chris Champion" NAME="Norris 1990" TYPE="JOURNAL_ARTICLE">
<AU>Norris R, Carroll D, Cochrane R</AU>
<TI>The effects of aerobic and anaerobic training on fitness, blood pressure, and psychological stress and well-being</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>1990</YR>
<VL>34</VL>
<NO>4</NO>
<PG>367-75</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2376838"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ogawa-2002" MODIFIED="2010-04-12 12:31:36 +0100" MODIFIED_BY="Chris Champion" NAME="Ogawa 2002" TYPE="JOURNAL_ARTICLE">
<AU>Ogawa O, Perry G, Smith MA</AU>
<TI>The "Down's" side of mitochondria</TI>
<SO>Dev Cell</SO>
<YR>2002</YR>
<VL>2</VL>
<NO>3</NO>
<PG>255-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11879629"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pastore-2003" MODIFIED="2010-04-12 12:32:05 +0100" MODIFIED_BY="Chris Champion" NAME="Pastore 2003" TYPE="JOURNAL_ARTICLE">
<AU>Pastore A, Tozzi G, Gaeta LM, Giannotti A, Bertini E, Federici G et al</AU>
<TI>Glutathione metabolism and antioxidant enzymes in children with Down syndrome</TI>
<SO>Journal of Pediatrics</SO>
<YR>2003</YR>
<VL>142</VL>
<NO>5</NO>
<PG>583-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pitetti-1992" MODIFIED="2010-04-12 12:32:22 +0100" MODIFIED_BY="Chris Champion" NAME="Pitetti 1992" TYPE="JOURNAL_ARTICLE">
<AU>Pitetti KH, Climstein M, Campbell KD, Barret PJ, Jackson JA</AU>
<TI>The cardiovascular capacities of adults with Down syndrome: a comparative study</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>1992</YR>
<VL>24</VL>
<NO>1</NO>
<PG>13-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1532223"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pitetti-1995" MODIFIED="2010-04-12 12:32:32 +0100" MODIFIED_BY="Chris Champion" NAME="Pitetti 1995" TYPE="JOURNAL_ARTICLE">
<AU>Pitetti KH, Boneh S</AU>
<TI>Cardiovascular fitness as related to leg strength in adults with mental retardation</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>1995</YR>
<VL>27</VL>
<NO>3</NO>
<PG>423-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7752871"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Resta-2003" MODIFIED="2010-04-12 12:32:46 +0100" MODIFIED_BY="Chris Champion" NAME="Resta 2003" TYPE="JOURNAL_ARTICLE">
<AU>Resta O, Barbaro MP, Giliberti T, Caratozzolo G, Cagnazzo MG, Scarpelli F et al</AU>
<TI>Sleep related breathing disorders in adults with Down syndrome</TI>
<SO>Down's Syndrome, Research and Practice</SO>
<YR>2003</YR>
<VL>8</VL>
<NO>3</NO>
<PG>115-9</PG>
<IDENTIFIERS MODIFIED="2009-11-04 21:57:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 21:57:47 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14502839"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Roat-2007" MODIFIED="2010-04-12 12:33:04 +0100" MODIFIED_BY="Chris Champion" NAME="Roat 2007" TYPE="JOURNAL_ARTICLE">
<AU>Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L et al</AU>
<TI>Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome</TI>
<SO>FEBS Letters</SO>
<YR>2007</YR>
<VL>581</VL>
<NO>3</NO>
<PG>521-5</PG>
<IDENTIFIERS MODIFIED="2009-11-07 00:14:38 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-07 00:14:38 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17250829"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Roberts-1996" MODIFIED="2010-04-12 12:33:15 +0100" MODIFIED_BY="Chris Champion" NAME="Roberts 1996" TYPE="JOURNAL_ARTICLE">
<AU>Roberts TJ, Weber J-M, Hoppeler H, Weibel ER, Taylor CR</AU>
<TI>Design of the oxygen and substrate pathways. II. Defining the upper limits of carbohydrate and fat oxidation</TI>
<SO>Journal of Experimental Biology</SO>
<YR>1996</YR>
<VL>199</VL>
<PG>1651-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Saenz-1999" NAME="Saenz 1999" TYPE="JOURNAL_ARTICLE">
<AU>Saenz R</AU>
<TI>Primary Care of Infants and Young Children with Down Syndrome</TI>
<SO>American Family Physician</SO>
<YR>1999</YR>
<VL>59</VL>
<PG>381-401</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schjerve-2008" MODIFIED="2010-04-12 12:34:04 +0100" MODIFIED_BY="Chris Champion" NAME="Schjerve 2008" TYPE="JOURNAL_ARTICLE">
<AU>Schjerve IE, Tyldum GA, Tjønna AE, Stølen T, Loennechen JP, Hansen HE et al</AU>
<TI>Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults</TI>
<SO>Clinical Science</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>9</NO>
<PG>283-93</PG>
<IDENTIFIERS MODIFIED="2009-11-09 13:12:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-09 13:12:44 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18338980"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schloo-1991" MODIFIED="2010-04-12 12:34:11 +0100" MODIFIED_BY="Chris Champion" NAME="Schloo 1991" TYPE="JOURNAL_ARTICLE">
<AU>Schloo BL, Vawter GF, Reid LM</AU>
<TI>Down syndrome: Patterns of disturbed lung growth</TI>
<SO>Human Pathology</SO>
<YR>1991</YR>
<VL>22</VL>
<NO>9</NO>
<PG>919-23</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1833304"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Seggar-1998" MODIFIED="2010-04-12 12:34:26 +0100" MODIFIED_BY="Chris Champion" NAME="Seggar 1998" TYPE="JOURNAL_ARTICLE">
<AU>Segar ML, Katch VL, Roth RS, Garcia AW, Portner TI, Glickman SG et al</AU>
<TI>The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1998</YR>
<VL>25</VL>
<NO>1</NO>
<PG>107-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spurway-1992" MODIFIED="2010-04-12 12:34:47 +0100" MODIFIED_BY="Chris Champion" NAME="Spurway 1992" TYPE="JOURNAL_ARTICLE">
<AU>Spurway NC</AU>
<TI>Aerobic exercise, anaerobic exercise and the lactate threshold</TI>
<SO>British Medical Bulletin</SO>
<YR>1992</YR>
<VL>48</VL>
<NO>3</NO>
<PG>569-91</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1450885"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stewart-2003" MODIFIED="2010-04-12 12:35:04 +0100" MODIFIED_BY="Chris Champion" NAME="Stewart 2003" TYPE="JOURNAL_ARTICLE">
<AU>Stewart KJ, Turner KL, Bacher AC, DeRegis Jr, Sung J, Tayback M et al</AU>
<TI>Are fitness, activity, and fatness associated with health-related quality of life and mood in older persons?</TI>
<SO>Journal of Cardiopulmonary Rehabilitation</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>2</NO>
<PG>115-21</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12668934"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Swain-1994" MODIFIED="2010-04-12 12:35:29 +0100" MODIFIED_BY="Chris Champion" NAME="Swain 1994" TYPE="JOURNAL_ARTICLE">
<AU>Swain DP, Abernathy KS, Smith CS, Lee SJ, Bunn SA</AU>
<TI>Target heart rates for the development of cardiorespiratory fitness</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>1994</YR>
<VL>26</VL>
<NO>1</NO>
<PG>112-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8133731"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Travis-1930" MODIFIED="2010-04-12 12:35:39 +0100" MODIFIED_BY="Chris Champion" NAME="Travis 1930" TYPE="JOURNAL_ARTICLE">
<AU>Travis LE, Dorsey JM</AU>
<TI>The relationship of "intelligence" and reflex conduction rate as found in hypophrenic children</TI>
<SO>Journal of Experimental Psychology</SO>
<YR>1930</YR>
<VL>13</VL>
<NO>4</NO>
<PG>370-2</PG>
<IDENTIFIERS MODIFIED="2009-09-23 00:26:20 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-09-23 00:26:20 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2005-14788-001"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Uhlig-1992" MODIFIED="2010-04-12 12:36:12 +0100" MODIFIED_BY="Chris Champion" NAME="Uhlig 1992" TYPE="JOURNAL_ARTICLE">
<AU>Uhlig S, Wendel A</AU>
<TI>The physiological consequences of glutathione variations</TI>
<SO>Life Sciences</SO>
<YR>1992</YR>
<VL>51</VL>
<NO>14</NO>
<PG>1083-94</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1518371"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Uong-2001" MODIFIED="2010-04-12 12:36:30 +0100" MODIFIED_BY="Chris Champion" NAME="Uong 2001" TYPE="JOURNAL_ARTICLE">
<AU>Uong EC, McDonough JM, Tayag-Kier CE, Zhao H, Haselgrove J, Mahboubi S et al</AU>
<TI>Magnetic resonance imaging of the upper airways in children with Down syndrome</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2001</YR>
<VL>163</VL>
<NO>3 Pt 1</NO>
<PG>731-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11254532"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Urv-2008" MODIFIED="2009-11-07 11:48:47 +0000" MODIFIED_BY="[Empty name]" NAME="Urv 2008" TYPE="JOURNAL_ARTICLE">
<AU>Urv TK, Zigman WB, Silverman W</AU>
<TI>Maladaptive behaviors related to dementia status in adults with Down syndrome</TI>
<SO>American Journal of Mental Retardation</SO>
<YR>2008</YR>
<VL>113</VL>
<NO>2</NO>
<PG>73-86</PG>
<IDENTIFIERS MODIFIED="2009-11-07 11:48:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-07 11:48:47 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18240877"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-USDHHS-2002" NAME="USDHHS 2002" TYPE="OTHER">
<AU>United States Department of Health and Human Services</AU>
<TI>Physical activity fundamental to preventing disease</TI>
<SO>www.hhs.gov</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vilas-Boas-2009" MODIFIED="2010-04-12 12:36:47 +0100" MODIFIED_BY="Chris Champion" NAME="Vilas Boas 2009" TYPE="JOURNAL_ARTICLE">
<AU>Vilas Boas LT, Albernaz EP, Costa RG</AU>
<TI>Prevalence of congenital heart defects in patients with Down syndrome</TI>
<SO>Jornal de Pediatria</SO>
<YR>2009</YR>
<VL>85</VL>
<NO>5</NO>
<PG>403-7</PG>
<IDENTIFIERS MODIFIED="2009-11-04 21:13:01 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 21:13:01 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9662319"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ware-1992" MODIFIED="2010-04-12 12:37:06 +0100" MODIFIED_BY="Chris Champion" NAME="Ware 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ware JE Jr, Sherbourne CD</AU>
<TI>The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection</TI>
<SO>Medical Care</SO>
<YR>1992</YR>
<VL>30</VL>
<NO>6</NO>
<PG>473-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wasserman-1973" MODIFIED="2010-04-12 12:37:16 +0100" MODIFIED_BY="Chris Champion" NAME="Wasserman 1973" TYPE="JOURNAL_ARTICLE">
<AU>Wasserman K, Whipp BJ, Koyl SN, Beaver WL</AU>
<TI>Anaerobic threshold and respiratory gas exchange during exercise</TI>
<SO>Journal of Applied Physiology</SO>
<YR>1973</YR>
<VL>35</VL>
<NO>2</NO>
<PG>236-43</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="4723033"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-WHO-2009" MODIFIED="2009-11-04 22:51:16 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2009" TYPE="OTHER">
<AU>WHO</AU>
<TI>Genes and human disease</TI>
<SO>http://www.who.int/genomics/public/geneticdiseases/en/index1.html</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-04-12 11:43:22 +0100" MODIFIED_BY="Chris Champion">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-04-12 11:43:22 +0100" MODIFIED_BY="Chris Champion" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-04-12 11:42:50 +0100" MODIFIED_BY="Chris Champion" STUDY_ID="STD-Carmelli-2002">
<CHAR_METHODS MODIFIED="2009-09-22 18:41:55 +0100" MODIFIED_BY="[Empty name]">
<P>Single-center, parallel RCT.</P>
<P>Location: Israel</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-09-20 00:33:16 +0100" MODIFIED_BY="[Empty name]">
<P>26 participants with Down syndrome. Age range: 57 to 65 years. Mean age: 63 years. Intelligence quotients (Stanford Binet Scale): 56 to 75. Cardiac disease: 15%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-09-21 12:26:52 +0100" MODIFIED_BY="[Empty name]">
<P>Low endurance walking at 0% incline, 3 times/week, for 25 consecutive weeks, initially for 10 to 15 minutes and then gradually for as long as 45 minutes (at a speed below the threshold of breathlessness).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-04-12 11:42:50 +0100" MODIFIED_BY="Chris Champion">
<P>(1) Average power %BW for Knee extension (angular velocity at 60°/s), (2) Average power %BW for knee flexion (angular velocity at 60°/s), (3) walking performance (timed-up and go test, seconds).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-09-22 19:40:16 +0100" MODIFIED_BY="[Empty name]">
<P>Knee flexion and extension variables at angular velocities of 120°/s were not considered for analysis, since average power %BW was more one surrogate outcome, but composed by more than one variable.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-09-23 00:08:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Millar-1993">
<CHAR_METHODS MODIFIED="2009-09-22 18:44:33 +0100" MODIFIED_BY="[Empty name]">
<P>Single-center, parallel RCT.</P>
<P>Location: USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]">
<P>14 participants with Down syndrome. Age, 18.4 years ± 2.9 (SD) and 17.0 years ± 2.8 (SD); weight, 66.5 Kg ± 12.5 (SD) and 58.4 Kg ± 25.3 (SD); height, 153.7 cm ± 7.1 (SD) and 150.0 cm ± 15.8 (SD) age, 18.4 years ± 2.9 (SD) and 17.0 years ± 2.8 (SD); weight, 66.5 Kg ± 12.5 (SD) and 58.4 Kg ± 25.3 (SD); height, 153.7 cm ± 7.1 (SD) and 150.0 cm ± 15.8 (SD). Setting: county schools (living at home).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]">
<P>Supervised 30 minutes of outside brisk/walking and jogging training with initial 10 minutes to warm-up, and 5 to 10 minutes to cool-down. Intensity: 65% - 75% of maximal HR. Session duration: 30 minutes. Period of training: 10 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]">
<P>(1) Maximal heart rate, (2) Peak oxygen consumption (VO2 peak), (3) Respiratory exchange ratio (RER), (4) Pulmonary ventilation (VE), (5) Maximal treadmill grade (percentage of incline / gradient).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-09-23 00:08:47 +0100" MODIFIED_BY="[Empty name]">
<P>Maximal exercise test time was not reported. Biased method of monitoring of heart rate during the training bouts (at random, by palpation after subject slowing down the speed). Informations not published: (1) the way in which exercise was performed: outside walking/jogging; (2) allocation concealment "using slips pulled by another person (first two slips with names to exercise, next one to control)"; (3) absence of blinding assessors of outcomes; and (4) anomaly in ECG as cause for one withdrawal (7% of randomised participants).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-04-12 11:43:22 +0100" MODIFIED_BY="Chris Champion" STUDY_ID="STD-Varela-2001">
<CHAR_METHODS MODIFIED="2009-09-22 18:44:43 +0100" MODIFIED_BY="[Empty name]">
<P>Single-center, parallel RCT.</P>
<P>Location: Portugal.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]">
<P>16 males with Down syndrome. Age, 22.0 years ± 3.8 (SD) and 20.8 years ± 2.3 (SD); weight, 62.6 Kg ± 10.7 (SD) and 60.1 Kg ± 10.6 (SD); height, 153.6 cm ± 7.0 (SD) and 157.3 cm ± 4.1 (SD); IQ, 39.4 ± 12.2 (SD) and 38.4 ± 7.4 (SD). Setting: Local vocational and education training centers.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]">
<P>Supervised rowing training sessions on Gjessing 'Ergorow' ergometer, 3 times per week, for 16 weeks. Duration of exercise bouts: phase 1 (weeks 1-6), 15 minutes per session ; phase 2 (weeks 6-10), 5 minutes to total every 2 weeks til participants reached 25 mins per session; and phase 3 (weeks 10-16), maintenance at 25 minutes per session. Intensities of training: 75% of peak HR (heart rate) registered on TM GXT (treadmill graded exercise test) on phases 1 and 2 of study, and 79% of peak HR obtained on TM GXT on phase 3; The intensities mentioned corresponded with 83% of peak HR obtained from RE GXT (rowing ergometer graded exercise test) on phase 1 and phase 2, and 89% of peak HR in RE GXT on phase 3.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-15 13:03:11 +0100" MODIFIED_BY="[Empty name]">
<P>(1) Maximal heart rate; (2) Peak oxygen consumption (VO2peak); (3) Respiratory exchange ratio (RER); (4) Pulmonary ventilation (VE); (5) Maximal test time (min); (6) Maximal treadmill grade (%); (7) Maximal rowing resistance (Kg); (8) Distance (meters); (9) Total turns of fan wheel; (10) Weight (Kg); (11) Body fat (%); (12) Lean mass (Kg), (13) Fat mass (Kg) , and (14) Bone mineral content (Kg); (15) Red blood cells Mg (mg/L), (16) Red blood cells Se (microgram/L), (17) Red blood cells Cu (microgram/L), (18) Red blood cells Zn (mg/L), (19) Plasma Mg (mg/L); (20) Plasma Se (microgram/L), (21) Plasma Cu (mg/L) and (22) Plasma Zn (mg/L); (23) Red blood cells SOD (U/mg Hb); (24) Red blood cells GSH (microgram/ g Hg) and (25) Red blood cells GSSG (microgram/ g Hg), (26) Plasma GSH (microgram/g prot.) and (27) Plasma GSSG (microgram/g prot.); (28) Plasma TBARS (mM).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-04-12 11:43:22 +0100" MODIFIED_BY="Chris Champion">
<P>Outcomes 12, 13 and 14 were extracted from Baptista 1996. Outcomes 15 to 28 were extracted from Monteiro 1997. The authors did not report any measure of adherence.<BR/>Outcomes 1, 2, 3, 4 and 5 were measured on both TM GXT and RE GXT;<BR/>Oucomes 7 and 9 were measured only on RE GXT;<BR/>Outcomes 6 and 8 were measured only on TM GXT;<BR/>Outcomes 10 to 28 were measured at rest.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-09-19 23:44:00 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Agiovlasitis-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:26 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aguiar-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:28 +0100" MODIFIED_BY="[Empty name]">
<P>Case-series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-18 11:37:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Angulo_x002d_Barroso-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-18 11:37:28 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial. Clinical condition out of interest (infants)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Black-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:31 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Black-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:34 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bricout-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:40 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carmeli-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:46 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chang-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:48 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dupont-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:50 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomized controlled trial. Clinical condition out of interest</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dyer-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-series. Participants 8-13 years old. Intervention: aerobic exercise combined together with weight training</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:12:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eberhard-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:12:57 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eberhard-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eberhard-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eberhard-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flore-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:02 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Galli-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:04 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guerra-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:10 +0100" MODIFIED_BY="[Empty name]">
<P>Accuracy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heffernan-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:13 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lafferty-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-series. Participants: Children</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-17 03:13:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-LaForme-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-17 03:13:56 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomized controlled trial. Intervention out of interest. Clinical condition out of interest (children)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-18 02:13:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-LaForme-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-18 02:13:18 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomized controlled trial. Intervention out of interest. Clinical condition out of interest.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lewis-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-report. Participants: Children</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lloyd-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:20 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mendon_x00e7_a-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:23 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mendon_x00e7_a-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:25 +0100" MODIFIED_BY="[Empty name]">
<P>Case-series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ordo_x00f1_ez-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Per_x00e1_n-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case-series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:16:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rimmer-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:16:51 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Intervention out of interest: aerobic exercise combined together with muscular strength and endurance training and education program. Current for another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-18 11:31:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shields-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-18 11:31:46 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial. Intervention out of interest (resistance training)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Skrobak-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:33 +0100" MODIFIED_BY="[Empty name]">
<P>Case-series. Intervention: Mixed activities.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:13:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:13:36 +0100" MODIFIED_BY="[Empty name]">
<P>Case-control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:19:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsimaras-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:19:05 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomized controlled trial. Intervention: aerobic exercise combined together with both dynamic balance activities and plyometric exercises</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-19 22:20:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ulrich-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-19 22:20:11 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Clinical condition out of interest for this review: mean age, 307 days.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-18 03:14:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weber-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-18 03:14:18 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention ou of interest (strength development training programs). Clinical condition out of interest (children)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-11-10 21:14:09 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2009-11-10 16:36:11 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-20 23:28:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carmelli-2002">
<DESCRIPTION>
<P>Coin toss</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-10 16:36:11 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Millar-1993">
<DESCRIPTION>
<P>"slips pulled by another person"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-15 17:57:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Varela-2001">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-11-06 20:00:21 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-20 23:30:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carmelli-2002">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-22 19:23:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Millar-1993">
<DESCRIPTION>
<P>"slips pulled by another person"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-15 17:57:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Varela-2001">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-11-10 21:14:09 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-10 21:13:19 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Carmelli-2002">
<DESCRIPTION>
<P>blinding of outcome assessors was not explicitly reported, and the characteristic of the intervention group (supervised physical exercise training) and control group (absence of supervised physical exercise training) would prevent participants and coaches to be blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-10 21:13:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Millar-1993">
<DESCRIPTION>
<P>patiens, therapists and outcome assessors were aware of the allocated group (<LINK REF="REF-Millar-2004" TYPE="REFERENCE">Millar 2004</LINK>)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-10 21:14:09 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Varela-2001">
<DESCRIPTION>
<P>blinding of outcome assessors was not explicitly reported, and the characteristic of the intervention group (supervised physical exercise training) and control group (absence of supervised physical exercise training) would prevent participants and coaches to be blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-11-06 20:00:21 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-09-23 00:52:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carmelli-2002">
<DESCRIPTION>
<P>no suspected withdrawals.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-15 18:10:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Millar-1993">
<DESCRIPTION>
<P>There was only 1 withdrawal after randomization and missing data could not be acquired because information concerning such matters was kept confidential on ethical grounds.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-15 17:57:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Varela-2001">
<DESCRIPTION>
<P>no suspected withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2009-11-06 20:00:21 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-21 00:30:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carmelli-2002">
<DESCRIPTION>
<P>none suspected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-22 19:23:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Millar-1993">
<DESCRIPTION>
<P>none suspected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-21 13:32:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Varela-2001">
<DESCRIPTION>
<P>none suspected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2009-11-10 19:42:32 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Free of detection bias?</NAME>
<DESCRIPTION>
<P>Was there a blinded assessment of outcomes?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2009-09-21 00:21:20 +0100" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2010-04-21 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2010-03-22 12:41:39 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Aerobic exercise training programmes versus no intervention (data collection on treadmill test)</NAME>
<CONT_OUTCOME CHI2="0.09348084045650609" CI_END="3.774400436150742" CI_START="-3.1734446500917564" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.3004778930294929" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2010-03-22 12:25:11 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7597977865094772" P_Q="0.7597977865094772" P_Z="0.8653816429478958" Q="0.09348084045650609" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="12" UNITS="" WEIGHT="100.00000000000001" Z="0.16952762797041154">
<NAME>Peak VO2 (mL·Kg -1·min-1)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.501425751535079" CI_START="-7.861425751535078" DF="0" EFFECT_SIZE="-0.6799999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.01" MODIFIED="2010-03-22 12:24:26 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8527690587311503" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="4" WEIGHT="23.400164607070753" Z="0.18558647761586153">
<NAME>Walking/jogging training programmes</NAME>
<CONT_DATA CI_END="6.501425751535078" CI_START="-7.861425751535077" EFFECT_SIZE="-0.6799999999999997" ESTIMABLE="YES" MEAN_1="25.56" MEAN_2="26.24" MODIFIED="2010-03-22 12:24:26 +0000" MODIFIED_BY="[Empty name]" ORDER="39" SD_1="7.82" SD_2="5.15" SE="3.6640600583384426" STUDY_ID="STD-Millar-1993" TOTAL_1="9" TOTAL_2="4" WEIGHT="23.400164607070753"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.569229520747291" CI_START="-3.369229520747295" DF="0" EFFECT_SIZE="0.5999999999999979" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" MODIFIED="2010-03-22 12:24:41 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7670210552419683" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="76.59983539292926" Z="0.29627371876006436">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="4.569229520747291" CI_START="-3.369229520747295" EFFECT_SIZE="0.5999999999999979" ESTIMABLE="YES" MEAN_1="31.7" MEAN_2="31.1" MODIFIED="2010-03-22 12:24:41 +0000" MODIFIED_BY="[Empty name]" ORDER="40" SD_1="4.0" SD_2="4.1" SE="2.0251543151078635" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="76.59983539292926"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.72473032082673" CI_END="10.731728119060161" CI_START="-5.046734305561404" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="2.8424969067493793" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2010-03-22 12:29:24 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.39459667355172856" P_Q="0.39459667355172856" P_Z="0.4800782396301432" Q="0.72473032082673" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="12" UNITS="" WEIGHT="99.99999999999999" Z="0.7061767380707139">
<NAME>Peak heart rate (beats per minute)</NAME>
<GROUP_LABEL_1>Favours Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="12.206955353199502" CI_START="-17.40695535319955" DF="0" EFFECT_SIZE="-2.6000000000000227" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" MODIFIED="2010-03-22 12:29:22 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7307287761886074" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="4" WEIGHT="28.388198595402816" Z="0.3441562588829613">
<NAME>Walking/jogging training programmes</NAME>
<CONT_DATA CI_END="12.206955353199502" CI_START="-17.40695535319955" EFFECT_SIZE="-2.6000000000000227" ESTIMABLE="YES" MEAN_1="167.2" MEAN_2="169.8" MODIFIED="2010-03-22 12:29:22 +0000" MODIFIED_BY="[Empty name]" ORDER="41" SD_1="11.8" SD_2="12.9" SE="7.554707877284939" STUDY_ID="STD-Millar-1993" TOTAL_1="9" TOTAL_2="4" WEIGHT="28.388198595402816"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="14.322714509101123" CI_START="-4.322714509101123" DF="0" EFFECT_SIZE="5.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" MODIFIED="2010-03-22 12:29:23 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.2931774749048447" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="71.61180140459717" Z="1.0511766624552734">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="14.322714509101123" CI_START="-4.322714509101123" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="171.0" MEAN_2="166.0" MODIFIED="2010-03-22 12:29:23 +0000" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="10.0" SD_2="9.0" SE="4.756574397610112" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="71.61180140459717"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.04149010861575856" CI_START="-0.06149010861575858" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2010-03-22 12:37:21 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.7034639844600694" Q="0.0" RANDOM="YES" SCALE="0.5" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="12" UNITS="" WEIGHT="100.0" Z="0.3806486405313599">
<NAME>Respiratory exchange ratio (VCO2/VO2)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intevention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.07698011113454704" CI_START="-0.09698011113454706" DF="0" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" MODIFIED="2010-03-22 12:36:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8217188839711336" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="4" WEIGHT="35.043518094365545" Z="0.22533472985660408">
<NAME>Walking/jogging training programmes</NAME>
<CONT_DATA CI_END="0.07698011113454704" CI_START="-0.09698011113454706" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="1.03" MEAN_2="1.04" MODIFIED="2010-03-22 12:36:24 +0000" MODIFIED_BY="[Empty name]" ORDER="43" SD_1="0.11" SD_2="0.05" SE="0.04437842318564783" STUDY_ID="STD-Millar-1993" TOTAL_1="9" TOTAL_2="4" WEIGHT="35.043518094365545"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.05388700961062044" CI_START="-0.07388700961062046" DF="0" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" MODIFIED="2010-03-22 12:36:35 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7590062689689917" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="64.95648190563445" Z="0.3067859955389484">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="0.05388700961062044" CI_START="-0.07388700961062046" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="1.05" MODIFIED="2010-03-22 12:36:35 +0000" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="0.07" SD_2="0.06" SE="0.03259601202601325" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="64.95648190563445"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6530591666583392" CI_END="16.06322695882554" CI_START="-4.3361932369190725" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="5.863516860953233" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2010-03-22 12:38:53 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.41902134552870296" P_Q="0.41902134552870296" P_Z="0.259858227303035" Q="0.6530591666583392" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="12" UNITS="" WEIGHT="99.99999999999999" Z="1.1267263245657362">
<NAME>Pulmonary ventilation (L·min-1)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="16.59396308847027" CI_START="-14.593963088470272" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" MODIFIED="2010-03-22 12:38:03 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.899979411248548" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="4" WEIGHT="42.78215457702078" Z="0.12568735564015765">
<NAME>Walking/jogging training programmes</NAME>
<CONT_DATA CI_END="16.593963088470275" CI_START="-14.593963088470273" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="49.82" MEAN_2="48.82" MODIFIED="2010-03-22 12:38:03 +0000" MODIFIED_BY="[Empty name]" ORDER="45" SD_1="13.24" SD_2="13.24" SE="7.95624981452387" STUDY_ID="STD-Millar-1993" TOTAL_1="9" TOTAL_2="4" WEIGHT="42.78215457702078"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="22.984103522554953" CI_START="-3.9841035225549533" DF="0" EFFECT_SIZE="9.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.02" MODIFIED="2010-03-22 12:38:20 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.16732204137308818" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="57.2178454229792" Z="1.3808599008443745">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="22.984103522554953" CI_START="-3.9841035225549533" EFFECT_SIZE="9.5" ESTIMABLE="YES" MEAN_1="74.7" MEAN_2="65.2" MODIFIED="2010-03-22 12:38:20 +0000" MODIFIED_BY="[Empty name]" ORDER="46" SD_1="17.6" SD_2="8.3" SE="6.879771071772666" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="57.2178454229792"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.27002812792999237" CI_END="6.452277750583092" CI_START="2.059067181180633" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="4.2556724658818625" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2010-03-22 12:41:39 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6033129555550379" P_Q="0.6033129555550379" P_Z="1.4633563996981365E-4" Q="0.27002812792999237" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="12" UNITS="" WEIGHT="100.0" Z="3.7972069088697045">
<NAME>Maximal treadmill grade (%)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="8.564644739850026" CI_START="1.435355260149974" DF="0" EFFECT_SIZE="5.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.01" MODIFIED="2010-03-22 12:40:45 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.005974610675889013" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="4" WEIGHT="37.97270549015523" Z="2.749171555062897">
<NAME>Walking/jogging training programmes</NAME>
<CONT_DATA CI_END="8.564644739850026" CI_START="1.435355260149974" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="23.1" MEAN_2="18.1" MODIFIED="2010-03-22 12:40:45 +0000" MODIFIED_BY="[Empty name]" ORDER="47" SD_1="4.1" SD_2="2.4" SE="1.8187297154271653" STUDY_ID="STD-Millar-1993" TOTAL_1="9" TOTAL_2="4" WEIGHT="37.97270549015523"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.589077645370528" CI_START="1.0109223546294732" DF="0" EFFECT_SIZE="3.8000000000000007" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.02" MODIFIED="2010-03-22 12:40:39 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.00757682007345699" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="62.027294509844765" Z="2.6703678019199653">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="6.589077645370528" CI_START="1.0109223546294732" EFFECT_SIZE="3.8000000000000007" ESTIMABLE="YES" MEAN_1="18.1" MEAN_2="14.3" MODIFIED="2010-03-22 12:40:39 +0000" MODIFIED_BY="[Empty name]" ORDER="48" SD_1="1.8" SD_2="3.6" SE="1.4230249470757708" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="62.027294509844765"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.23919092653084" CI_START="0.9608090734691586" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.0999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2010-03-22 12:21:19 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.004507480041008856" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="2.8402739917785316">
<NAME>Maximal test time (minutes)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.23919092653084" CI_START="0.9608090734691586" DF="0" EFFECT_SIZE="3.0999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.01" MODIFIED="2010-03-22 12:20:27 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.004507480041008856" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="2.8402739917785316">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="5.23919092653084" CI_START="0.9608090734691586" EFFECT_SIZE="3.0999999999999996" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="12.9" MODIFIED="2010-03-22 12:20:27 +0000" MODIFIED_BY="[Empty name]" ORDER="49" SD_1="1.3" SD_2="2.8" SE="1.0914439976471537" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="390.07252722859096" CI_START="98.52747277140898" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="244.29999999999995" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2010-03-22 12:23:14 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.0010209056141342486" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="3.2847012432752996">
<NAME>Maximal distance (meters)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="390.07252722859096" CI_START="98.52747277140898" DF="0" EFFECT_SIZE="244.29999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.01" MODIFIED="2010-03-22 12:22:40 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0010209056141342486" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="3.2847012432752996">
<NAME>Walking/Jogging training programmes</NAME>
<CONT_DATA CI_END="390.07252722859096" CI_START="98.52747277140898" EFFECT_SIZE="244.29999999999995" ESTIMABLE="YES" MEAN_1="1207.3" MEAN_2="963.0" MODIFIED="2010-03-22 12:22:40 +0000" MODIFIED_BY="[Empty name]" ORDER="50" SD_1="148.5" SD_2="149.0" SE="74.37510504194263" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2010-03-22 12:48:17 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Aerobic exercise training programmes versus no intervention (data collection on rowing ergometer test)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.740767786542872" CI_START="-5.140767786542869" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2010-03-22 12:42:38 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5446207934178315" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.605840323708932">
<NAME>Peak VO2 (mL·Kg -1·min-1)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.740767786542872" CI_START="-5.140767786542869" DF="0" EFFECT_SIZE="2.3000000000000007" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" MODIFIED="2010-03-22 12:42:13 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5446207934178315" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.605840323708932">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="9.740767786542872" CI_START="-5.140767786542869" EFFECT_SIZE="2.3000000000000007" ESTIMABLE="YES" MEAN_1="30.0" MEAN_2="27.7" MODIFIED="2010-03-22 12:42:13 +0000" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="9.1" SD_2="5.7" SE="3.796379854545643" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="24.07530963337807" CI_START="-18.07530963337807" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2010-03-22 12:43:25 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.7802491741187874" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.27899433298516624">
<NAME>Peak heart rate (beats per minute)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="24.07530963337807" CI_START="-18.07530963337807" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" MODIFIED="2010-03-22 12:43:04 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7802491741187874" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.27899433298516624">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="24.07530963337807" CI_START="-18.07530963337807" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="152.0" MEAN_2="149.0" MODIFIED="2010-03-22 12:43:04 +0000" MODIFIED_BY="[Empty name]" ORDER="52" SD_1="21.0" SD_2="22.0" SE="10.752906583803284" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.3858288892880031" CI_START="-0.4458288892880031" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2010-03-22 12:44:37 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.8875525968017651" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.14140171847338281">
<NAME>Respiratory exchange ratio (VCO2/VO2)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3858288892880031" CI_START="-0.4458288892880031" DF="0" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" MODIFIED="2010-03-22 12:44:03 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8875525968017651" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.14140171847338281">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="0.3858288892880031" CI_START="-0.4458288892880031" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="1.01" MEAN_2="1.04" MODIFIED="2010-03-22 12:44:03 +0000" MODIFIED_BY="[Empty name]" ORDER="53" SD_1="0.6" SD_2="0.01" SE="0.21216149509277124" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="25.525974908500693" CI_START="-12.725974908500696" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="6.399999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2010-03-22 12:45:33 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.511920684332209" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="99.99999999999999" Z="0.6558499402548711">
<NAME>Pulmonary ventilation (L·min-1)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="25.525974908500693" CI_START="-12.725974908500696" DF="0" EFFECT_SIZE="6.399999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" MODIFIED="2010-03-22 12:45:09 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.511920684332209" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999" Z="0.6558499402548711">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="25.525974908500693" CI_START="-12.725974908500696" EFFECT_SIZE="6.399999999999999" ESTIMABLE="YES" MEAN_1="67.3" MEAN_2="60.9" MODIFIED="2010-03-22 12:45:09 +0000" MODIFIED_BY="[Empty name]" ORDER="54" SD_1="16.4" SD_2="22.2" SE="9.75832977512033" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.559486647773937" CI_START="1.0605133522260624" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.3099999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2010-03-22 12:46:32 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="2.906414618593357E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="3.6235015494992813">
<NAME>Maximal test time (minutes)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.559486647773937" CI_START="1.0605133522260624" DF="0" EFFECT_SIZE="2.3099999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.01" MODIFIED="2010-03-22 12:46:05 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="2.906414618593357E-4" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="3.6235015494992813">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="3.559486647773937" CI_START="1.0605133522260624" EFFECT_SIZE="2.3099999999999996" ESTIMABLE="YES" MEAN_1="9.62" MEAN_2="7.31" MODIFIED="2010-03-22 12:46:05 +0000" MODIFIED_BY="[Empty name]" ORDER="55" SD_1="0.97" SD_2="1.52" SE="0.637504901941938" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="16.669962111767724" CI_START="1.490037888232279" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="9.080000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2010-03-22 12:47:34 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.019040451396215526" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="2.344738052385198">
<NAME>Distance (total turns of fan wheel divided by 100)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="16.669962111767724" CI_START="1.490037888232279" DF="0" EFFECT_SIZE="9.080000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.01" MODIFIED="2010-03-22 12:47:00 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.019040451396215526" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="2.344738052385198">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="16.669962111767724" CI_START="1.490037888232279" EFFECT_SIZE="9.080000000000002" ESTIMABLE="YES" MEAN_1="33.7" MEAN_2="24.62" MODIFIED="2010-03-22 12:47:00 +0000" MODIFIED_BY="[Empty name]" ORDER="56" SD_1="7.74" SD_2="7.75" SE="3.8725008069721563" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.36268753186483715" CI_START="0.07731246813516321" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2200000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2010-03-22 12:48:17 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.00251166626302131" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.00000000000001" Z="3.0219324068711613">
<NAME>Resistance (Kg)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.36268753186483715" CI_START="0.07731246813516321" DF="0" EFFECT_SIZE="0.2200000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.01" MODIFIED="2010-03-22 12:47:56 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.00251166626302131" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.00000000000001" Z="3.0219324068711613">
<NAME>Rowing traning programmes</NAME>
<CONT_DATA CI_END="0.36268753186483715" CI_START="0.07731246813516321" EFFECT_SIZE="0.2200000000000002" ESTIMABLE="YES" MEAN_1="1.87" MEAN_2="1.65" MODIFIED="2010-03-22 12:47:56 +0000" MODIFIED_BY="[Empty name]" ORDER="57" SD_1="0.1" SD_2="0.18" SE="0.07280109889280519" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2010-03-22 13:54:58 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Aerobic exercise training programmes versus no intervention (data collection at rest)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="7.809939190078076" CI_START="-12.009939190078079" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.1000000000000014" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2010-03-22 12:49:11 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6778981777645976" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.4153329590210824">
<NAME>Weight (Kg)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.809939190078076" CI_START="-12.009939190078079" DF="0" EFFECT_SIZE="-2.1000000000000014" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.01" MODIFIED="2010-03-22 12:48:48 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6778981777645976" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.4153329590210824">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="7.809939190078076" CI_START="-12.009939190078079" EFFECT_SIZE="-2.1000000000000014" ESTIMABLE="YES" MEAN_1="59.9" MEAN_2="62.0" MODIFIED="2010-03-22 12:48:48 +0000" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="10.6" SD_2="9.6" SE="5.05618433208284" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.921931687986886" CI_START="-5.72193168798689" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4000000000000021" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2010-03-22 12:50:12 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.5255004093877989" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.6348896226155263">
<NAME>Body fat (%)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.921931687986886" CI_START="-5.72193168798689" DF="0" EFFECT_SIZE="-1.4000000000000021" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.01" MODIFIED="2010-03-22 12:49:49 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5255004093877989" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.6348896226155263">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="2.921931687986886" CI_START="-5.72193168798689" EFFECT_SIZE="-1.4000000000000021" ESTIMABLE="YES" MEAN_1="21.4" MEAN_2="22.8" MODIFIED="2010-03-22 12:49:49 +0000" MODIFIED_BY="[Empty name]" ORDER="59" SD_1="4.1" SD_2="4.7" SE="2.205107707119995" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.6654553496095286" CI_START="-4.865455349609531" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2010-03-22 12:50:57 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.7827798734210223" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.2756982067182317">
<NAME>Lean mass (Kg)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.6654553496095286" CI_START="-4.865455349609531" DF="0" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.01" MODIFIED="2010-03-22 12:50:37 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7827798734210223" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.2756982067182317">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="3.6654553496095286" CI_START="-4.865455349609531" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" MEAN_1="43.9" MEAN_2="44.5" MODIFIED="2010-03-22 12:50:37 +0000" MODIFIED_BY="[Empty name]" ORDER="60" SD_1="4.2" SD_2="4.5" SE="2.1762927192820363" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.458562239058401" CI_START="-8.458562239058402" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.04" MODIFIED="2010-03-22 12:51:42 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.6726649856519186" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.00000000000001" Z="0.4224933076416516">
<NAME>Fat mass (Kg)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.458562239058401" CI_START="-8.458562239058402" DF="0" EFFECT_SIZE="-1.5" ESTIMABLE="YES" I2="0.0" ID="CMP-003.04.01" MODIFIED="2010-03-22 12:51:20 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6726649856519186" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.00000000000001" Z="0.4224933076416516">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="5.4585622390584" CI_START="-8.4585622390584" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="15.6" MODIFIED="2010-03-22 12:51:20 +0000" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="7.2" SD_2="7.0" SE="3.5503520952153464" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.14925575810238284" CI_START="-0.44925575810238266" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.1499999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.05" MODIFIED="2010-03-22 12:52:11 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.3258933918782857" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="99.99999999999999" Z="0.9824191839958688">
<NAME>Bone content mineral (Kg)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14925575810238284" CI_START="-0.44925575810238266" DF="0" EFFECT_SIZE="-0.1499999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.01" MODIFIED="2010-03-22 12:52:11 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3258933918782857" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999" Z="0.9824191839958688">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="0.14925575810238284" CI_START="-0.44925575810238266" EFFECT_SIZE="-0.1499999999999999" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="2.05" MODIFIED="2010-03-22 12:52:11 +0000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="0.29" SD_2="0.32" SE="0.1526843148460247" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.412944982499536" CI_START="-3.4129449824995364" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.06" MODIFIED="2010-03-22 12:53:17 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.6569415990749379" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.4441396827544202">
<NAME>Red blood cells magnesium (mg/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.412944982499536" CI_START="-3.4129449824995364" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" ID="CMP-003.06.01" MODIFIED="2010-03-22 12:52:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6569415990749379" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.4441396827544202">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="5.412944982499536" CI_START="-3.4129449824995364" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="42.2" MEAN_2="41.2" MODIFIED="2010-03-22 12:52:51 +0000" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="2.84" SD_2="5.7" SE="2.2515439147393947" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="23.743031386882123" CI_START="-18.94303138688211" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.4000000000000057" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.07" MODIFIED="2010-03-22 12:54:04 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.8255629496256037" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.22039575717380366">
<NAME>Red blood cells selenium (mg/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="23.743031386882123" CI_START="-18.94303138688211" DF="0" EFFECT_SIZE="2.4000000000000057" ESTIMABLE="YES" I2="0.0" ID="CMP-003.07.01" MODIFIED="2010-03-22 12:53:40 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8255629496256037" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.22039575717380366">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="23.743031386882123" CI_START="-18.94303138688211" EFFECT_SIZE="2.4000000000000057" ESTIMABLE="YES" MEAN_1="97.0" MEAN_2="94.6" MODIFIED="2010-03-22 12:53:40 +0000" MODIFIED_BY="[Empty name]" ORDER="64" SD_1="18.4" SD_2="24.7" SE="10.889501825152516" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="138.2106896755606" CI_START="-156.41068967556063" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-9.100000000000023" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.08" MODIFIED="2010-03-22 12:54:57 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.9036314665826009" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="99.99999999999999" Z="0.12107520709186893">
<NAME>Red blood cells copper (microgram/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="138.2106896755606" CI_START="-156.41068967556063" DF="0" EFFECT_SIZE="-9.100000000000023" ESTIMABLE="YES" I2="0.0" ID="CMP-003.08.01" MODIFIED="2010-03-22 12:54:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9036314665826009" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999" Z="0.12107520709186893">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="138.2106896755606" CI_START="-156.41068967556063" EFFECT_SIZE="-9.100000000000023" ESTIMABLE="YES" MEAN_1="751.9" MEAN_2="761.0" MODIFIED="2010-03-22 12:54:31 +0000" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="144.2" SD_2="156.2" SE="75.1598962213227" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.4031467277450562" CI_START="-2.403146727745056" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.09" MODIFIED="2010-03-22 12:55:38 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.6066039035658446" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.5149271876851865">
<NAME>Red blood cells zinc (mg/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.4031467277450562" CI_START="-2.403146727745056" DF="0" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" ID="CMP-003.09.01" MODIFIED="2010-03-22 12:55:16 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6066039035658446" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.5149271876851865">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="1.4031467277450562" CI_START="-2.403146727745056" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="14.9" MEAN_2="15.4" MODIFIED="2010-03-22 12:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="1.02" SD_2="2.55" SE="0.9710110709976483" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.7077458062244799" CI_START="-1.70774580622448" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.10" MODIFIED="2010-03-22 12:56:19 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.4171279045430467" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.8114141131514564">
<NAME>Plasma magnesium (mg/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7077458062244799" CI_START="-1.70774580622448" DF="0" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" ID="CMP-003.10.01" MODIFIED="2010-03-22 12:55:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4171279045430467" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.8114141131514564">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="0.7077458062244797" CI_START="-1.7077458062244797" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="19.9" MEAN_2="20.4" MODIFIED="2010-03-22 12:55:57 +0000" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="1.36" SD_2="1.09" SE="0.616208162880045" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.321414187090955" CI_START="-17.121414187090966" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.900000000000006" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.11" MODIFIED="2010-03-22 12:57:01 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.1858086835646784" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="1.3230802749785917">
<NAME>Plasma selenium (microgram/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.321414187090955" CI_START="-17.121414187090966" DF="0" EFFECT_SIZE="-6.900000000000006" ESTIMABLE="YES" I2="0.0" ID="CMP-003.11.01" MODIFIED="2010-03-22 12:56:37 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.1858086835646784" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="1.3230802749785917">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="3.321414187090955" CI_START="-17.121414187090966" EFFECT_SIZE="-6.900000000000006" ESTIMABLE="YES" MEAN_1="65.0" MEAN_2="71.9" MODIFIED="2010-03-22 12:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="68" SD_1="6.78" SD_2="13.1" SE="5.21510306705438" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.13117650348280924" CI_START="-0.1911765034828093" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.12" MODIFIED="2010-03-22 12:58:50 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.7152526880723489" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.3648107401862893">
<NAME>Plasma copper (mg/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13117650348280924" CI_START="-0.1911765034828093" DF="0" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.01" MODIFIED="2010-03-22 12:58:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7152526880723489" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.3648107401862893">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="0.13117650348280924" CI_START="-0.1911765034828093" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="1.13" MEAN_2="1.16" MODIFIED="2010-03-22 12:58:24 +0000" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="0.1" SD_2="0.21" SE="0.08223442101699263" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.02151302866747984" CI_START="-0.21848697133252037" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.1200000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.13" MODIFIED="2010-03-22 13:54:58 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.01693622799394306" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="2.3880892565039757">
<NAME>Plasma zinc (mg/L)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.02151302866747984" CI_START="-0.21848697133252037" DF="0" EFFECT_SIZE="-0.1200000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-003.13.01" MODIFIED="2010-03-22 13:54:58 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.01693622799394306" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="2.3880892565039757">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="-0.02151302866747984" CI_START="-0.21848697133252037" EFFECT_SIZE="-0.1200000000000001" ESTIMABLE="YES" MEAN_1="0.98" MEAN_2="1.1" MODIFIED="2010-03-22 12:59:29 +0000" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="0.11" SD_2="0.09" SE="0.05024937810560445" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="599.0665930389739" CI_START="-511.0665930389739" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="44.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.14" MODIFIED="2010-03-22 13:00:57 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="0.8765328733671435" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="0.1553658901495215">
<NAME>Red blood cells superoxide dismutase (U/mg Hb)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="599.0665930389739" CI_START="-511.0665930389739" DF="0" EFFECT_SIZE="44.0" ESTIMABLE="YES" I2="0.0" ID="CMP-003.14.01" MODIFIED="2010-03-22 13:00:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8765328733671435" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="0.1553658901495215">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="599.0665930389739" CI_START="-511.0665930389739" EFFECT_SIZE="44.0" ESTIMABLE="YES" MEAN_1="3192.0" MEAN_2="3148.0" MODIFIED="2010-03-22 13:00:31 +0000" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="210.0" SD_2="773.0" SE="283.2024452578049" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="64.65785846429134" CI_START="-586.6578584642914" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-261.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.15" MODIFIED="2010-03-22 13:02:13 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.11622394944985491" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="1.5708222192987433">
<NAME>Red blood cells reduced glutatione (microgram/g Hb)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="64.65785846429134" CI_START="-586.6578584642914" DF="0" EFFECT_SIZE="-261.0" ESTIMABLE="YES" I2="0.0" ID="CMP-003.15.01" MODIFIED="2010-03-22 13:01:48 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.11622394944985491" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="1.5708222192987433">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="64.65785846429134" CI_START="-586.6578584642914" EFFECT_SIZE="-261.0" ESTIMABLE="YES" MEAN_1="1608.0" MEAN_2="1869.0" MODIFIED="2010-03-22 13:01:48 +0000" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="151.7" SD_2="444.8" SE="166.15502174174574" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="59.74678501444121" CI_START="38.6532149855588" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="49.2" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.16" MODIFIED="2010-03-22 13:03:08 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="6.069159629935493E-20" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="9.143092222637836">
<NAME>Red blood cells oxidized glutathione (microgram/g Hb)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="59.74678501444121" CI_START="38.6532149855588" DF="0" EFFECT_SIZE="49.2" ESTIMABLE="YES" I2="0.0" ID="CMP-003.16.01" MODIFIED="2010-03-22 13:02:34 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="6.069159629935493E-20" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="9.143092222637836">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="59.74678501444121" CI_START="38.6532149855588" EFFECT_SIZE="49.2" ESTIMABLE="YES" MEAN_1="99.2" MEAN_2="50.0" MODIFIED="2010-03-22 13:02:34 +0000" MODIFIED_BY="[Empty name]" ORDER="73" SD_1="11.5" SD_2="9.97" SE="5.381111641659184" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="254.97237870568574" CI_START="84.82762129431423" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="169.89999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.17" MODIFIED="2010-03-22 13:04:12 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="9.067096439813725E-5" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="3.9142890564443507">
<NAME>Plasma reduced glutathione (microgram/g prot/10)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="254.97237870568574" CI_START="84.82762129431423" DF="0" EFFECT_SIZE="169.89999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-003.17.01" MODIFIED="2010-03-22 13:03:36 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="9.067096439813725E-5" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="3.9142890564443507">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="254.97237870568574" CI_START="84.82762129431423" EFFECT_SIZE="169.89999999999998" ESTIMABLE="YES" MEAN_1="836.8" MEAN_2="666.9" MODIFIED="2010-03-22 13:03:36 +0000" MODIFIED_BY="[Empty name]" ORDER="74" SD_1="52.45" SD_2="111.0" SE="43.40507242823124" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.319329329281593E-32" CI_END="1.6707469404873088" CI_START="-22.470746940487317" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-10.400000000000004" ESTIMABLE="YES" I2="100.00000000000001" I2_Q="0.0" ID="CMP-003.18" MODIFIED="2010-03-22 13:05:03 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.0" P_Q="1.0" P_Z="0.09128082605986976" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="100.0" Z="1.688679709691077">
<NAME>Plasma oxidized glutathione (microgram/g prot)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.319329329281593E-32" CI_END="1.6707469404873088" CI_START="-22.470746940487317" DF="0" EFFECT_SIZE="-10.400000000000004" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-003.18.01" MODIFIED="2010-03-22 13:04:41 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.09128082605986976" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0" Z="1.688679709691077">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="1.670746940487307" CI_START="-22.470746940487317" EFFECT_SIZE="-10.400000000000006" ESTIMABLE="YES" MEAN_1="61.0" MEAN_2="71.4" MODIFIED="2010-03-22 13:04:41 +0000" MODIFIED_BY="[Empty name]" ORDER="75" SD_1="6.65" SD_2="16.1" SE="6.158657524168722" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.004900518334685522" CI_START="-4.555099481665315" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.2800000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.19" MODIFIED="2010-03-22 13:05:48 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.0" P_Q="1.0" P_Z="0.04950855968958939" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="99.99999999999999" Z="1.964185707378535">
<NAME>Plasma thiobarbituric acid reactive substances (mM)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.004900518334685522" CI_START="-4.555099481665315" DF="0" EFFECT_SIZE="-2.2800000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-003.19.01" MODIFIED="2010-03-22 13:05:23 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.04950855968958939" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999" Z="1.964185707378535">
<NAME>Rowing training programmes</NAME>
<CONT_DATA CI_END="-0.004900518334685522" CI_START="-4.555099481665315" EFFECT_SIZE="-2.2800000000000002" ESTIMABLE="YES" MEAN_1="5.21" MEAN_2="7.49" MODIFIED="2010-03-22 13:05:23 +0000" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="1.63" SD_2="2.85" SE="1.1607863713879485" STUDY_ID="STD-Varela-2001" TOTAL_1="8" TOTAL_2="8" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.8143842364532006" CI_END="19.65108121640116" CI_START="16.001135532367307" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="17.826108374384233" ESTIMABLE="YES" I2="64.46824896730377" I2_Q="64.46824896730377" ID="CMP-003.20" MODIFIED="2010-03-22 13:08:40 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.09342284209093077" P_Q="0.09342284209093077" P_Z="0.0" Q="2.8143842364532006" RANDOM="NO" SCALE="36.59" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="12" TOTAL_2="14" UNITS="" WEIGHT="100.0" Z="19.14468511196447">
<NAME>Average power for Knee extension (watts/Kg-angular velocity at 60/°s)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="20.076522649024767" CI_START="16.323477350975224" DF="0" EFFECT_SIZE="18.199999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-003.20.01" MODIFIED="2010-03-22 13:07:54 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="6" TOTAL_2="4" WEIGHT="94.58128078817734" Z="19.009280030362202">
<NAME>Men</NAME>
<CONT_DATA CI_END="20.076522649024767" CI_START="16.323477350975224" EFFECT_SIZE="18.199999999999996" ESTIMABLE="YES" MEAN_1="58.4" MEAN_2="40.2" MODIFIED="2010-03-22 13:07:54 +0000" MODIFIED_BY="[Empty name]" ORDER="39" SD_1="2.0" SD_2="1.0" SE="0.9574271077563381" STUDY_ID="STD-Carmelli-2002" TOTAL_1="6" TOTAL_2="4" WEIGHT="94.58128078817734"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="19.139855938160213" CI_START="3.46014406183978" DF="0" EFFECT_SIZE="11.299999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-003.20.02" MODIFIED="2010-03-22 13:08:04 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.004728061603285956" STUDIES="1" TAU2="0.0" TOTAL_1="6" TOTAL_2="10" WEIGHT="5.418719211822659" Z="2.8249999999999993">
<NAME>Women</NAME>
<CONT_DATA CI_END="19.139855938160213" CI_START="3.46014406183978" EFFECT_SIZE="11.299999999999997" ESTIMABLE="YES" MEAN_1="45.4" MEAN_2="34.1" MODIFIED="2010-03-22 13:08:04 +0000" MODIFIED_BY="[Empty name]" ORDER="40" SD_1="9.0" SD_2="5.0" SE="4.0" STUDY_ID="STD-Carmelli-2002" TOTAL_1="6" TOTAL_2="10" WEIGHT="5.418719211822659"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.6026686434395847" CI_END="24.582868217169697" CI_START="16.56049723872355" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="20.571682727946623" ESTIMABLE="YES" I2="72.24279835390945" I2_Q="72.24279835390945" ID="CMP-003.21" MODIFIED="2010-03-22 13:09:08 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.05768707317556443" P_Q="0.05768707317556443" P_Z="9.017642636769096E-24" Q="3.6026686434395847" RANDOM="NO" SCALE="36.59" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="16" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="10.051830651184774">
<NAME>Average power for Knee flexion (watts/Kg-angular velocity at 60/°s)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="21.861307485973285" CI_START="5.7386925140267095" DF="0" EFFECT_SIZE="13.799999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-003.21.01" MODIFIED="2009-09-20 22:25:57 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="7.930036551215615E-4" STUDIES="1" TAU2="0.0" TOTAL_1="6" TOTAL_2="4" WEIGHT="24.75908080059304" Z="3.3552253196786657">
<NAME>Men</NAME>
<CONT_DATA CI_END="21.861307485973285" CI_START="5.7386925140267095" EFFECT_SIZE="13.799999999999997" ESTIMABLE="YES" MEAN_1="39.9" MEAN_2="26.1" MODIFIED="2009-09-20 22:25:57 +0100" MODIFIED_BY="[Empty name]" ORDER="43" SD_1="8.0" SD_2="5.0" SE="4.112987559751022" STUDY_ID="STD-Carmelli-2002" TOTAL_1="6" TOTAL_2="4" WEIGHT="24.75908080059304"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="27.424296786380673" CI_START="18.17570321361932" DF="0" EFFECT_SIZE="22.799999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-003.21.02" MODIFIED="2009-09-20 22:26:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="4.306247906281065E-22" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="6" WEIGHT="75.24091919940696" Z="9.663562031555678">
<NAME>Women</NAME>
<CONT_DATA CI_END="27.424296786380673" CI_START="18.17570321361932" EFFECT_SIZE="22.799999999999997" ESTIMABLE="YES" MEAN_1="33.8" MEAN_2="11.0" MODIFIED="2009-09-20 22:26:32 +0100" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="7.0" SD_2="2.0" SE="2.359378449224852" STUDY_ID="STD-Carmelli-2002" TOTAL_1="10" TOTAL_2="6" WEIGHT="75.24091919940696"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2010-04-21 14:39:36 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Aerobic exercise training programmes versus no intervention (data collection on medical isokinetic system)</NAME>
<CONT_OUTCOME CHI2="3.6113780025284434" CI_END="19.53033551084966" CI_START="15.910119609251467" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="17.720227560050564" ESTIMABLE="YES" I2="72.30973885038155" I2_Q="72.30973885038155" ID="CMP-004.01" MODIFIED="2010-04-21 14:39:36 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.057385730544428526" P_Q="0.057385730544428526" P_Z="0.0" Q="3.6113780025284434" RANDOM="NO" SCALE="36.59" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="16" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="19.18725775455586">
<NAME>Average power for Knee extension (watts/Kg-angular velocity at 60/°s)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="20.076522649024767" CI_START="16.323477350975224" DF="0" EFFECT_SIZE="18.199999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-004.01.01" MODIFIED="2009-09-21 13:03:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="6" TOTAL_2="4" WEIGHT="93.04677623261693" Z="19.009280030362202">
<NAME>Men</NAME>
<CONT_DATA CI_END="20.076522649024767" CI_START="16.323477350975224" EFFECT_SIZE="18.199999999999996" ESTIMABLE="YES" MEAN_1="58.4" MEAN_2="40.2" MODIFIED="2009-09-21 13:03:48 +0100" MODIFIED_BY="[Empty name]" ORDER="75" SD_1="2.0" SD_2="1.0" SE="0.9574271077563381" STUDY_ID="STD-Carmelli-2002" TOTAL_1="6" TOTAL_2="4" WEIGHT="93.04677623261693"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="18.164538940612196" CI_START="4.435461059387796" DF="0" EFFECT_SIZE="11.299999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-004.01.02" MODIFIED="2009-09-21 13:03:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.001253679462274681" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="6" WEIGHT="6.953223767383059" Z="3.2263773600689074">
<NAME>Women</NAME>
<CONT_DATA CI_END="18.164538940612196" CI_START="4.435461059387796" EFFECT_SIZE="11.299999999999997" ESTIMABLE="YES" MEAN_1="45.4" MEAN_2="34.1" MODIFIED="2009-09-21 13:03:48 +0100" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="9.0" SD_2="5.0" SE="3.5023801430836525" STUDY_ID="STD-Carmelli-2002" TOTAL_1="10" TOTAL_2="6" WEIGHT="6.953223767383059"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.6026686434395847" CI_END="24.582868217169697" CI_START="16.56049723872355" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="20.571682727946623" ESTIMABLE="YES" I2="72.24279835390945" I2_Q="72.24279835390945" ID="CMP-004.02" MODIFIED="2010-04-21 14:39:36 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.05768707317556443" P_Q="0.05768707317556443" P_Z="9.017642636769096E-24" Q="3.6026686434395847" RANDOM="NO" SCALE="36.59" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="16" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="10.051830651184774">
<NAME>Average power for Knee flexion (watts/Kg-angular velocity at 60/°s)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="21.861307485973285" CI_START="5.7386925140267095" DF="0" EFFECT_SIZE="13.799999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.01" MODIFIED="2010-03-22 13:11:21 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="7.930036551215615E-4" STUDIES="1" TAU2="0.0" TOTAL_1="6" TOTAL_2="4" WEIGHT="24.75908080059304" Z="3.3552253196786657">
<NAME>Men</NAME>
<CONT_DATA CI_END="21.861307485973285" CI_START="5.7386925140267095" EFFECT_SIZE="13.799999999999997" ESTIMABLE="YES" MEAN_1="39.9" MEAN_2="26.1" MODIFIED="2009-09-21 13:03:48 +0100" MODIFIED_BY="[Empty name]" ORDER="77" SD_1="8.0" SD_2="5.0" SE="4.112987559751022" STUDY_ID="STD-Carmelli-2002" TOTAL_1="6" TOTAL_2="4" WEIGHT="24.75908080059304"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="27.424296786380673" CI_START="18.17570321361932" DF="0" EFFECT_SIZE="22.799999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.02" MODIFIED="2009-09-21 13:03:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="4.306247906281065E-22" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="6" WEIGHT="75.24091919940696" Z="9.663562031555678">
<NAME>Women</NAME>
<CONT_DATA CI_END="27.424296786380673" CI_START="18.17570321361932" EFFECT_SIZE="22.799999999999997" ESTIMABLE="YES" MEAN_1="33.8" MEAN_2="11.0" MODIFIED="2009-09-21 13:03:48 +0100" MODIFIED_BY="[Empty name]" ORDER="78" SD_1="7.0" SD_2="2.0" SE="2.359378449224852" STUDY_ID="STD-Carmelli-2002" TOTAL_1="10" TOTAL_2="6" WEIGHT="75.24091919940696"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2010-04-21 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Aerobic exercise training programmes versus no intervention (data collection on Timed-up and go test (s))</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.570260223111625" CI_START="0.8297397768883803" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2010-04-21 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.0081431919011914" Q="0.0" RANDOM="YES" SCALE="24.36" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="16" UNITS="" WEIGHT="100.0" Z="2.646074337903116">
<NAME>Timed-up and go test (s)</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Intervention</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.570260223111625" CI_START="0.8297397768883803" EFFECT_SIZE="3.200000000000003" ESTIMABLE="YES" MEAN_1="29.1" MEAN_2="25.9" MODIFIED="2010-03-22 13:10:39 +0000" MODIFIED_BY="[Empty name]" ORDER="84" SD_1="3.0" SD_2="3.0" SE="1.2093386622447824" STUDY_ID="STD-Carmelli-2002" TOTAL_1="10" TOTAL_2="16" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2009-11-10 21:52:18 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Produção - Down.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2009-09-23 00:39:15 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Cumulative relative frequency of studies retrieved with a sensitive search strategy used across all databases (from their inception to August/2009). The oldest study observed was published in 1930 (<LINK REF="REF-Travis-1930" TYPE="REFERENCE">Travis 1930</LINK>).</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="fluxograma def.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2009-09-23 01:18:58 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Flow chart of studies retrieved by the sensitive search strategy. Numbers in parentheses indicate secondary references and how many times they are repeated.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2009-11-10 21:52:18 +0000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each item of risk of bias presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2010-04-14 12:08:56 +0100" MODIFIED_BY="Chris Champion">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2010-04-14 12:08:56 +0100" MODIFIED_BY="Chris Champion" NO="1">
<TITLE MODIFIED="2010-04-14 11:36:34 +0100" MODIFIED_BY="Chris Champion">Comments regarding excluded study</TITLE>
<DATE_SUBMITTED>
<DATE DAY="28" MONTH="2" YEAR="2009"/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2010-04-14 12:08:56 +0100" MODIFIED_BY="Chris Champion">
<P>The study <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK>a has been excluded from this review on the grounds that it is not randomised. However, on page 107, under the heading "Walking Training Protocol", it states: "Participants in the study were randomly assigned to either the WG or the CG by means of a coin toss." This study has also been confirmed as being randomised by two independent raters on the PEDro database of randomised trials in physiotherapy: <A HREF="http://www.pedro.fhs.usyd.edu.au">www.pedro.fhs.usyd.edu.au</A>
</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2010-04-14 12:08:56 +0100" MODIFIED_BY="Chris Champion">
<P>We have now reassessed and included the <LINK REF="STD-Carmelli-2002" TYPE="STUDY">Carmelli 2002</LINK> trial and at the same time, thoroughly updated the review. We would like to thank Mark Elkins and the staff of PEDro database for their feedback, which has made us look again at this issue.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2010-04-14 11:46:26 +0100" MODIFIED_BY="Chris Champion">
<P>This feedback was prepared by Jane Dennis, feedback editor for CDPLPG, in consultation with the submitter, the authors, the co-ordinating editor and the managing editor.</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2010-04-12 11:44:55 +0100" MODIFIED_BY="Chris Champion">
<APPENDIX ID="APP-01" MODIFIED="2010-04-12 11:44:33 +0100" MODIFIED_BY="Chris Champion" NO="1">
<TITLE MODIFIED="2010-04-12 11:44:33 +0100" MODIFIED_BY="Chris Champion">General search strategy for clinical condition and intervention of interest used across all databases</TITLE>
<APPENDIX_BODY MODIFIED="2009-09-22 03:06:07 +0100" MODIFIED_BY="[Empty name]">
<P>#1 down syndrome</P>
<P>#2 syndrome, down</P>
<P>#3 mongolism</P>
<P>#4 trisomy 21</P>
<P>#5 down's syndrome</P>
<P>#6 downs syndrome</P>
<P>#7 syndrome, down's</P>
<P>#8 trisomy 21, meiotic nondisjunction</P>
<P>#9 trisomy 21, mitotic nondisjunction</P>
<P>#10 down syndrome, partial trisomy 21</P>
<P>#11 partial trisomy 21 down syndrome</P>
<P>
<B>#12 </B>#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11</P>
<P>#13 aerobic exercise</P>
<P>#14 aerobic exercises</P>
<P>#15 athletic</P>
<P>#16 bicycling</P>
<P>#17 calisthenic</P>
<P>#18 cyclic</P>
<P>#19 dance</P>
<P>#20 dancing</P>
<P>#21 physical train</P>
<P>#22 exercise activities</P>
<P>#23 exercise activity</P>
<P>#24 exercise behaviour</P>
<P>#25 exercise education</P>
<P>#26 exercise educations</P>
<P>#27 exercise intervention</P>
<P>#28 exercise interventions</P>
<P>#29 exercise lifestyle</P>
<P>#30 exercise program</P>
<P>#31 exercise recreation</P>
<P>#32 exercise recreations</P>
<P>#33 exercise study</P>
<P>#34 exercise therapy</P>
<P>#35 exercise training</P>
<P>#36 exercise, aerobic</P>
<P>#37 exercise, isometric</P>
<P>#38 exercise, physical</P>
<P>#39 exercise, warm-up</P>
<P>#40 exercises</P>
<P>#41 exercises, aerobic</P>
<P>#42 exercises, isometric</P>
<P>#43 exercises, physical</P>
<P>#44 xercises, warm-up</P>
<P>#45 exertion</P>
<P>#46 exertions</P>
<P>#47 football</P>
<P>#48 gymnastic</P>
<P>#49 isometric exercise</P>
<P>#50 isometric exercises</P>
<P>#51 mountaineer</P>
<P>#52 physical activities</P>
<P>#53 physical activity</P>
<P>#54 physical behavior</P>
<P>#55 physical behaviour</P>
<P>#56 physical education</P>
<P>#57 physical exercise</P>
<P>#58 physical exercises</P>
<P>#59 physical habit</P>
<P>#60 physical habits</P>
<P>#61 physical intervention</P>
<P>#62 physical interventions</P>
<P>#63 physical program</P>
<P>#64 physical programme</P>
<P>#65 physical programmes</P>
<P>#66 physical programs</P>
<P>#67 physical recreation</P>
<P>#68 physical studies</P>
<P>#69 physical study</P>
<P>#70 physical training</P>
<P>#71 ramble</P>
<P>#72 rambling</P>
<P>#73 rowing</P>
<P>#74 running</P>
<P>#75 skate</P>
<P>#76 skating</P>
<P>#77 soccer</P>
<P>#78 swim</P>
<P>#79 swimming</P>
<P>#80 training program</P>
<P>#81 training programme</P>
<P>#82 training programmes</P>
<P>#83 training programs</P>
<P>#84 walk</P>
<P>#85 walking</P>
<P>#86 warm up exercise</P>
<P>#87 warm-up exercise</P>
<P>#88 warm-up exercises</P>
<P>
<B>#89 </B>#13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71 OR #72 OR #73 OR #74 OR #75 OR #76 OR #77 OR #78 OR #79 OR #80 OR #81 OR #82 OR #83 OR #84 OR #85 OR #86 OR #87 OR #88</P>
<P>
<B>#89 </B>#12 AND #88</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2010-04-12 11:44:46 +0100" MODIFIED_BY="Chris Champion" NO="2">
<TITLE MODIFIED="2010-04-12 11:44:46 +0100" MODIFIED_BY="Chris Champion">Search filter for RCTs used in Medline (PUBMED)</TITLE>
<APPENDIX_BODY MODIFIED="2009-07-15 18:35:34 +0100" MODIFIED_BY="[Empty name]">
<P>#1 randomized controlled trial [pt]</P>
<P>#2 controlled clinical trial [pt]</P>
<P>#3 randomized controlled trials [mh]</P>
<P>#4 random allocation [mh]</P>
<P>#5 double-blind method [mh]</P>
<P>#6 single-blind method [mh]</P>
<P>#7 clinical trial [pt]</P>
<P>#8 clinical trials [mh]</P>
<P>
<B>#9 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8</B>
</P>
<P>#10 clinical trial [tw]</P>
<P>#11 singl* [tw]</P>
<P>#12 doubl* [tw]</P>
<P>#13 trebl* [tw]</P>
<P>#14 tripl* [tw])</P>
<P>
<B>#15 #10 OR #11 OR #12 OR #13 OR #14</B>
</P>
<P>#16 mask* [tw]</P>
<P>#17 blind* [tw]</P>
<P>
<B>#18 #16 OR #17</B>
</P>
<P>
<B>#19 #15 AND #18</B>
</P>
<P>#20 placebos [mh]</P>
<P>#21 placebo* [tw]</P>
<P>#22 random* [tw]</P>
<P>#23 research design [mh:noexp]</P>
<P>#24 comparative study [mh]</P>
<P>#25 evaluation studies [mh]</P>
<P>#26 follow-up studies [mh]</P>
<P>#27 prospective studies [mh]</P>
<P>#28 control* [tw]</P>
<P>#29 prospectiv* [tw]</P>
<P>#30 volunteer* [tw])</P>
<P>
<B>#31 #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30</B>
</P>
<P>#32(animals [mh] NOT human [mh])</P>
<P>
<B>#33 #9 OR #19 OR #31 NOT #32</B>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2009-07-13 17:08:39 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2009-07-13 17:04:54 +0100" MODIFIED_BY="[Empty name]">Search filter for RCTs used in Lilacs (Bireme)</TITLE>
<APPENDIX_BODY MODIFIED="2009-07-13 17:04:33 +0100" MODIFIED_BY="[Empty name]">
<P>#1 Pt RANDOMIZED CONTROLLED TRIAL</P>
<P>#2 Pt CONTROLLED CLINICAL TRIAL</P>
<P>#3 Mh RANDOMIZED CONTROLLED TRIALS</P>
<P>#4 Mh RANDOM ALLOCATION</P>
<P>#5 Mh DOUBLE-BLIND METHOD</P>
<P>#6 Mh SINGLE-BLIND METHOD</P>
<P>#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6</P>
<P>#8 Ct ANIMAL AND NOT (Ct HUMAN and Ct ANIMAL)</P>
<P>#9 #7 AND NOT #8</P>
<P>#10 Pt CLINICAL TRIAL</P>
<P>#11 Ex E05.318.760.535$ &lt;explode Mh CLINICAL TRIALS&gt;</P>
<P>#12 Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR</P>
<P>Tw experim$ OR Tw investiga$)</P>
<P>#13 Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR</P>
<P>Tw duplo$ OR Tw trebl$ OR Tw trip$</P>
<P>#14 Tw blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR</P>
<P>Tw mascar$</P>
<P>#15 #18 #13 AND #14</P>
<P>#16 Mh PLACEBOS</P>
<P>#17 Tw placebo$</P>
<P>#18 Tw random$ OR Tw randon$ OR Tw casual$ OR Tw acaso$</P>
<P>OR Tw azar OR Tw aleator$</P>
<P>#19 Mh RESEARCH DESIGN</P>
<P>#20 #10 OR #11 OR #12 OR #15 OR #16 OR #17 OR #18</P>
<P>OR #19</P>
<P>#21 Ct ANIMAL AND NOT (Ct HUMAN and Ct ANIMAL)</P>
<P>#22 #20 AND NOT #21</P>
<P>#23 #22 AND NOT #9</P>
<P>#24 Ct COMPARATIVE STUDY</P>
<P>#25 Ex E05.337$ &lt;explode Mh EVALUATION STUDIES)&gt;</P>
<P>#26 Mh FOLLOW-UP STUDIES</P>
<P>#27 Mh PROSPECTIVE STUDIES</P>
<P>#28 Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$</P>
<P>#29 #24 OR #25 OR #26 OR #27 OR #28</P>
<P>#30 Ct ANIMAL AND NOT (Ct HUMAN and Ct ANIMAL)</P>
<P>#31 #29 AND NOT #30</P>
<P>#32 #31 AND NOT (#9 OR #23)</P>
<P>#33 #9 OR #23 OR #32</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2010-04-12 11:44:55 +0100" MODIFIED_BY="Chris Champion" NO="4">
<TITLE MODIFIED="2010-04-12 11:44:55 +0100" MODIFIED_BY="Chris Champion">Search filter for RCTs for EMBASE</TITLE>
<APPENDIX_BODY MODIFIED="2009-07-13 17:06:28 +0100" MODIFIED_BY="[Empty name]">
<P>#1 random$</P>
<P>#2 factorial$</P>
<P>#3 crossover$</P>
<P>#4 cross over$</P>
<P>#5 placebo$</P>
<P>#6 doubl$ adj blind$</P>
<P>#7 singl$ adj blind$</P>
<P>#8 assign$</P>
<P>#9 allocat$</P>
<P>#10 volunteer$</P>
<P>#11 crossover-procedure</P>
<P>#12 double-blind procedure</P>
<P>#13 randomized controlled trial</P>
<P>#14 single-blind procedure</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2009-07-16 22:58:44 +0100" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2009-07-16 22:34:40 +0100" MODIFIED_BY="[Empty name]">Search Strategy - The Cochrane Library</TITLE>
<APPENDIX_BODY MODIFIED="2009-07-16 22:58:44 +0100" MODIFIED_BY="[Empty name]">
<P>#1     MeSH descriptor Down Syndrome explode all trees</P>
<P>#2     MeSH descriptor Exercise explode all trees</P>
<P>#3     MeSH descriptor Physical Education and Training explode all trees</P>
<P>#4     MeSH descriptor Swimming explode all trees</P>
<P>#5     MeSH descriptor Walking explode all trees</P>
<P>#6     MeSH descriptor Running explode all trees</P>
<P>#7     MeSH descriptor Motor Activity explode all trees</P>
<P>#8     MeSH descriptor Physical Fitness explode all trees</P>
<P>#9     MeSH descriptor Physical Therapy (Specialty) explode all trees</P>
<P>#10   MeSH descriptor Physical Endurance explode all trees</P>
<P>#11   MeSH descriptor Physical Therapy Modalities explode all trees</P>
<P>#12   (physical exercise$)</P>
<P>#13   (rowing)</P>
<P>#14   (EXERCISE TRAIN$)</P>
<P>#15   (TRAINING PROGRAM$)</P>
<P>#16   (physical education$)</P>
<P>#17   (training)</P>
<P>#18   (AEROBIC TRAINING)</P>
<P>#19   (#2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18)</P>
<P>#20   (#1 AND #19)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>